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The first study was initiated to develop a multiplexed genotyping platform to study 
many candidate genes of coronary artery disease (CAD) in the hope that disease-
susceptible SNPs could be rapidly identified.  For this purpose, 20 representative 
SNPs were chosen to develop a microarray-based genotyping platform using 
minisequencing.  Sequencing and RFLP were performed to serve as the gold standard 
and bench mark, respectively.  The array platform could call 90.5% of all genotypes, 
demonstrating great potential in interrogating multiple SNPs.  However, this platform 
can be improved if a better strategy is in use to replace the one-color approach, and if 
target amplification can be ensured and the probes are approximately designed. 
In the second study, we devised a novel two-color strategy and integrated it with 
universal tag/anti-tag system (TAT) and liquid-phase primer extension.  In brief, TAT 
allowed fabrication of universal arrays for any combination of SNPs, and liquid-phase 
primer extension facilitated efficient incorporation of ddNTPs, and the two-color 
scheme permitted all SNPs and some short insertions/deletions (INDELs) to be 
genotyped simultaneously using only two fluorescent ddNTPs.  This platform 
(TATLIPEXA) showed a remarkable concordance rate of 100% with both sequencing 
and RFLP.  Significantly, TATLIPEXA was potentially able to provide quantitative 
information on allele frequencies in pooled DNA samples. 
To utilize the unique feature of terminal deoxyribonucleotidyl transferase (TdT) in 
catalyzing polymerization in a template-independent manner, we developed a novel 
tool (TdT-assisted probe elongation, TAPE) in the third study.  By TAPE, 
oligonucleotide arrays could be fabricated with regular oligonucleotides.  Also by 
TAPE, introduction of fluorescence was enabled.  TAPE permitted detection of 
 vii
10fmols of oligonucleotides.  Significantly, TAPE could proceed very rapidly without 
using any sophisticated equipments.  The application of TAPE in genotyping SNPs 
was demonstrated by running allele-specific minisequencing with regular ddNTPs, 
followed by TAPE to introduce Cyanine 5-ddCTP.  All 5 representative SNPs were 
correctly genotyped using synthetic targets.  RNA fragments could be directly 
elongated by TAPE, indicating that it could also be used for gene expression studies. 
The fourth study was conducted because we observed that TdT could add fluorescent 
nucleotides into probes immobilized with 3'-NH2, despite the absence of 3'-OH group.  
This activity was subsequently observed on oligonucleotides with 3'-biotin and 3'-C3 
linker.  These modifiers have in common, an additional -OH group on the linkers.  In 
contrast, 3'-phosphorylated oligonucleotide was effective in blocking elongation by 
TdT because no extra -OH group was present.  Thus, a common belief that 3' 
chemically modified oligonucleotides could not be elongated was challenged.  This 
implied that -OH group which was not from DNA could also be recognized by TdT, 
and elongation by TdT could also proceed in a primer-independent manner.  This 
study also found that classical phosphodiester bonds were formed during such 
elongation. 
In summary, minisequencing was successfully adapted to solid support to genotype 
multiple SNPs, and a novel two-color strategy demonstrated great potential for 
genotyping all SNPs and some INDELs, and a versatile tool for both genotyping and 
gene expression was demonstrated.  Moreover, another unusual property of TdT was 
discovered during these efforts. 
Key words: single nucleotide polymorphisms (SNPs), microarray, minisequencing, 
tag/anti-tag system (TAT), liquid-phase primer extension, tag-anti-tag liquid phase 
primer extension array (TATLIPEXA), TdT-assisted probe elongation (TAPE) 
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CHAPTER 1 LITERATURE REVIEW 
 
1.1 Genetic variations in human genome 
The completion of the whole genome sequencing through Human Genome Project 
(HGP) is undoubtedly one of the most marvelous achievements in human history 
(Lander et al., 2001; Venter et al., 2001).  Consequently, a reference genome 
sequence is now available.  Logically, the next big inquiry of the post-genome era 
would be the interpretation of this so-called genetic blueprint.  The secrets lie within 
the simple double-helix polymers composed of only four basic nucleotides, but it can 
be a very long journey for inspired scientists with innovative technologies to decipher 
the meanings behind such polymers. 
In brief, the “central dogma of life” can be summarized as production of a particular 
protein is instructed by DNA via an intermediate called RNA.  Thus, there are three 
potential candidate target molecules which may facilitate the elucidation of the 
lifebook, and they are DNA, RNA and protein.  Only DNA will be discussed here. 
It is estimated that 99.9% of the genome sequences between any two individuals are 
identical, and the remaining 0.1% are represented by many genetic variations (Wang 
et al., 1998; Cargill et al., 1999).  Even though such variations are only a small 
fraction of the total genome, they are widely believed to be the reason why 
individuals are different from each other and why some are susceptible to certain 
diseases and resistant to certain drugs or even viruses like HIV while the others are 
not.  For these reasons, genetic variations are greatly valued for their great potential 
applications in biomedical studies, drug development and medical diagnostics.  
Unfortunately, there is a huge gap between genetic variations and complex 
phenotypes.  In order to bridge such gap, enormous funding from the public and 
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private sectors have been invested and a large number of scientists, converging from 
many fields, are intensely studying genetic variations, from which disease-genes are 
expected to be identified and personalized medicines developed.  Such efforts are 
more explicitly expressed through the International HapMap Project, which is “a 
partnership of scientists and funding agencies from Canada, China, Japan, Nigeria, the 
United Kingdom and the United States to develop a public resource that will help 
researchers find genes associated with human disease and response to 
pharmaceuticals” (http://www.hapmap.org). 
Many forms of genetic variations are randomly scattered throughout the whole 
genome.  For example, some nucleotide sequences are repeated many times in tandem, 
and they are named variable number tandem repeats (VNTRs).  Depending on the 
length, VNTRs can be further subdivided into microsatellites (usually 2-4 base pairs) 
and minisatellites (more than 12 base pairs).  There are also many insertions or 
deletions (INDELs) of various sizes that are distributed widely across the genome, but 
they are less frequent than VNTRs.  While many DNA sequences may vary in the 
number of copies (copy-number polymorphisms, CNPs) (Sebat et al., 2004; Iafrate et 
al., 2004), other chromosome segments may be clipped out, turned upside down and 
reinserted back into the chromosome (inversions) (Tuzun et al., 2005).  Nevertheless, 
the most abundant form of genetic variation identified thus far is single nucleotide 
polymorphisms, which accounts for about 90% of all variations in the genome 
(Sachidanandam et al., 2001). 
 
i) Single nucleotide polymorphisms (SNPs) 
SNPs (pronounced "snips") are arbitrarily defined as single-base substitutions, 
insertions or deletions at a frequency of 1% or higher in the population, thus 
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distinguishing themselves from rare mutations (<1%) (Collins et al., 1998; 
Brookes 1999).  It was reported that more than five million SNPs have been 
validated thus far (Rebbeck et al., 2004; Riva et al., 2004). 
A common belief is that SNPs result mainly from errors in DNA replication, 
despite the fact that such process is catalyzed and monitored by high-fidelity DNA 
polymerases.  SNPs can be either transitions (from a purine to another purine, or 
from a pyrimidine to another pyrimidine) or transversions (from a purine to a 
pyrimidine, or vice versa).  The former (G↔A and C↔T) are estimated to 
account for over two-thirds of all SNPs in the genome, and the remaining third are 
represented by the latter (C↔A, G↔T, C↔G and A↔T) (Wang et al., 1998).  
SNPs are randomly distributed throughout the entire genome, including introns, 
exons and regulatory regions.  Depending on whether the resultant amino acids 
are changed or not, SNPs located inside exons can be further subdivided into 
synonymous SNPs (no change) and non-synonymous SNPs (occurrence of amino 
acid change). 
 
ii) The need for SNP genotyping 
Even before the genome sequencing was completed, many researchers have 
focused their studies on genetic variations between individuals.  These variations 
can serve as good physical markers for other analysis.  More importantly, they are 
also believed to be involved in rendering individuals susceptibility to a particular 
common disease.  This is known as the “common variants-common disease” 
hypothesis (Collins et al., 1997).  SNPs also confer important influence on 
responses to medicines (Tsuchihashi et al., 2002).  Thus, it is quite attractive and 
 4
also imperative to develop molecular technologies to identify SNPs associated 
with diseases and drug responses. 
The challenges posed by associating SNPs with complex phenotypes can be seen 
in a few aspects.  Five million SNPs have been validated thus far, but it is 
expected that a few million more will be identified.  However, only a small 
fraction of these SNPs have potential influence on predisposition to diseases or 
resistance to drugs.  SNPs that are potentially associated with common diseases 
are themselves common in both healthy population and sick people.  From the 
point of diseases, the situation is also very complicated.  Many diseases (e.g., 
acquired immunodeficiency syndrome, AIDS) can be largely attributed to 
environmental factors such as social culture, economic, education, ethic and etc.  
In contrast, other diseases (such as cystic fibrosis, thalessemia and haemophilia, 
etc) are essentially caused by genetic variations of specific genes.  These are 
called Mendelian diseases.  However, the pathogenesis of most diseases, such as 
cardiovascular disorders and cancers, is attributed to both genetic and 
environmental factors to different extent.  Even if only genetic factors are 
considered, the association between these diseases and SNPs is still very difficult 
because they are more likely to be caused by multiple SNPs from a number of 
genes instead of a point mutation from a single gene.  Thus, it usually requires 
genotyping of a large number of SNPs among many individuals by association 
studies.  To meet these challenges, therefore, it is imperative to develop robust, 





1.2 Main events in the analysis of SNPs 
The analysis of SNPs embraces two different aspects, discovery and genotyping.  
Today, the complete SNP map of our genome is not available.  In order to identify the 
candidate SNPs, many gene- or disease-focused studies are still ongoing.  This 
constitutes the discovery aspect.  For such purpose, sequencing is often employed, but 
a few alternative approaches are also widely in use.  In principle, they are dependent 
on either differential electrophoretic mobility or chemical/enzymatic cleavage 
reactions (Fakhrai-Rad et al., 2002; Lilleberg 2003; Clifford et al., 2004; Twyman 
2004; Suh et al., 2005). 
However, more attention in the last decade has been given to the identification of 
SNPs potentially associated with diseases or drug responses, motivated by both 
scientific and industrial purposes.  This constitutes the aspect of genotyping.  Thus far, 
dozens of robust genotyping technologies are commercially available in the analysis 
of SNPs (Syvanen 2001; Dearlove 2002; Chen et al., 2003; Kwok et al., 2003; Olivier 
2005; Shen et al., 2005; Tost et al., 2005), and new approaches are continuously 
emerging because no method can satisfy the requirements of any linkage studies.  On 
the other hand, many current technologies need to be further improved in order to 
simplify the analysis, increase the throughput or lower the cost, etc. 
An ideal genotyping technology should have high sensitivity and specificity.  In other 
words, it should permit accurate allele discrimination and detection through an 
appropriate format on an appropriate instrument.  To meet the demands of large-scale 
association studies, multiplexing and automation should also be considered so that 
tens of thousands of SNPs can be interrogated simultaneously at an affordable price. 
This section discusses the three main events during SNPs analysis, i.e., target 
amplification, allele discrimination and detection.  It should be kept in mind that these 
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events may not be performed in such order.  For example, allele discrimination by the 
gap-filling reaction of the molecular inversion probe (MIP) technology (ParAllele) is 
carried out before the amplification of the target by universal PCR (Hardenbol et al., 
2003).  Since most technologies employ a target amplification strategy, Invader 
technology which amplifies the signal molecules will be discussed separately as an 
exception.  As the focus of this section is on the general principles of each event, 
which is often directly represented by traditional genotyping methodologies, array-
based technologies will not be discussed in detail. 
 
i) Target amplification 
As genomic DNA (gDNA) is normally a substance of very low abundance, 
amplification of DNA is usually considered first before any subsequent analysis.  
Fortunately, DNA regions of interest can be amplified at will by conventional 
PCR technology due to the complementary nature of double-stranded DNA 
(dsDNA) and our good understanding of DNA replication.  For some unknown 
reasons, however, DNA amplification is rarely addressed when SNP genotyping 
approaches including high-throughput ones are reviewed.  Frequently, only 
various allele discrimination biochemistries and detection approaches are 
meticulously discussed and compared.  It is true that targets are almost 
unanimously prepared by locus-specific PCR amplification for most traditional 
low-throughput technologies.  For high-throughput approaches, however, target 
amplification is very crucial for subsequent analysis.  For these reasons, a few 
alternative amplification methods have been developed.  Without an efficient 
target amplification procedure, many current platforms cannot be as robust and 
highly multiplexible as they are, which explains why such platforms endeavor to 
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introduce universal PCR primer sequences into the allele-discrimination 
oligonucleotides. 
Currently, target amplification is indispensible for most genotyping approaches.  
Other than locus-specific PCR, universal PCR amplification and whole genome 
amplification have also been successfully developed and widely applied to large-
scale or genome-wide association applications. 
 
a. Locus-specific PCR 
Usually, gDNA regions containing SNPs of interest are amplified by many 
PCR reactions with multiple locus-specific primers.  This amplification 
strategy is very simple and suitable for most gene- or diseases-focused 
association studies with a limited number of custom SNPs.  Indeed, it is still in 
use by some commercial high-throughput platforms such as homogenous 
MassEXTEND assay (hME, Sequenom).  Obviously, this approach is very 
time-consuming and labour-intensive, and it will consume a large amount of 
gDNA which is often precious and limiting.  To overcome this problem, 
multiplex PCR has been developed, by which a few loci of gDNA can be 
amplified simultaneously in a single reaction.  However, the capacity of 
multiplex PCR to amplify multiple targets simultaneously is limited.  As such, 
it is not well-suited for comprehensive association studies to analyze hundreds 
or thousands of SNPs. 
 
b. Universal PCR 
The application of universal PCR to amplify multiple loci of interest in a 
single reaction has significantly promoted the development of several 
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commercial high-throughput genotyping platforms such as SNPlex technology 
(Applied Biosystems) (De la Vega et al., 2005), GoldenGate Array (Illumina) 
(Shen et al., 2005) and MIP technology (Hardenbol et al., 2005).  The allele 
discrimination of these technologies is achieved by either oligonucleotide 
ligation assay (SNPlex), or allele-specific primer extension (GoldenGate), or 
single-base primer extension and ligation (MIP).  Regardless of the different 
allele discrimination biochemistry employed, one common effect of these 
approaches is to join two universal PCR primer sequences which are originally 
located on separate oligonucleotides.  Only if proper allele discrimination 
reaction takes place should both PCR primers be joined at the 5' and 3' ends of 
the full-length product, which is usually composed of locus-specific sequences, 
SNP site and a universal sequence.  Following this, the full-length product can 
be amplified by a universal PCR primer pair.  The main advantage of universal 
PCR amplification is that hundreds to thousands of loci of interest can be 
prepared simultaneously by one reaction.  For example, GoldenGate permits 
1,536 SNPs to be interrogated in a single reaction, and MIP has an even higher 
limit of 12,000 SNPs.  In average, less gDNA is required by universal PCR to 
produce sufficient target for each genotyping.  For instance, only 250-500ng 
of gDNA is required by GoldenGate and MIP technologies to interrogate 
1,536 and 12,000 SNPs, respectively.  Compared to typical locus-specific PCR, 
universal PCR amplifies much smaller regions of DNA flanking the SNP sites.  
Consequently, genomic sequence complexity is significantly reduced to 
facilitate accurate and specific genotyping.  Similar to locus-specific PCR, 
however, amplification by universal PCR still requires a large number of 
 9
tagged locus-specific oligonucleotides.  For each SNP, for example, SNPlex 
requires three locus-specific oligonucleotides and five universal probes. 
 
c. Whole genome amplification 
Genome-wide genotyping of hundreds of thousands of SNPs have been made 
possible by the development of whole genome amplification (WGA) 
technologies, which can be either PCR-dependent or entirely PCR-free 
(Hawkins et al., 2002; Hughes et al., 2005; Tzvetkov et al., 2005).  For 
example, GeneChip Mapping Array (Affymetrix) for whole genome analysis 
is based on PCR-WGA (Kennedy et al., 2003; Matsuzaki et al., 2004).  Briefly, 
gDNA is randomly cut by restriction enzymes into numerous fragments, 
which are subsequently flanked with the common adaptor sequence through 
ligation.  Following this, the whole genome can be amplified with only one 
generic primer to generate sufficient DNA fragments for genome-wide SNP 
mapping.  Recently, scientists from Illumina also reported a bead array-based 
whole-genome genotyping assay (WGG), by which no PCR is required at all 
(Gunderson et al., 2005).  The most obvious advantage of WGA over 
universal PCR is the complete elimination of locus-specific primers, which 
can number up to tens of thousand for MIP assay.  Today, only WGA-based 
genotyping technologies are potentially able to map the whole genome, it is 
thus expected that more WGA-dependent SNP genotyping technologies will 





ii) Allele discrimination 
Allele discrimination is a procedure by which the allele of a given sample is 
identified.  Undoubtedly, this is the heart of genotyping and has considerable 
impact on the whole assay.  For example, the specificity of any approach is largely 
determined by allele-discrimination biochemistry employed at this stage.  Allele 
discrimination can be achieved by many strategies, but only a few of them are 
discussed here, which include hybridization, primer extension, ligation and 
nuclease cleavage.  Indeed, many commercial genotyping platforms are based on 
one or more of these four mechanisms (Table 1.1). 
 
Table 1.1 Allele-discrimination chemistries of some commercial genotyping systems 
Commercial platforms* 
Chemistries 
GeneChip TaqMan MIP Invader SNPlex GoldenGate hME
hybridization √ √      
single-base 
extension (SBE)   √    √ 
multiple-base 
extension (MBE)      √ √ 
ligation   √  √ √  
nuclease cleavage  √  √    
* MIP: molecular inversion probe; hME: Homogenous MassEXTEND assay 
 
a. Hybridization 
The application of hybridization to analyze SNPs is based on two properties of 
DNA.  First, two complementary oligonucleotides will hybridize to form DNA 
duplex.  Second, perfectly matched duplex can be separated from single-
mismatched duplex under appropriate conditions due to their different 
thermodynamics (Hall et al., 2001; Urakawa et al., 2003).  This can be 
explained by the speculation that DNA duplex formation proceeds through a 
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transient nucleation complex from the interaction of very few base pairs and 
not from all base pairs simultaneously (Southern et al., 1999).  There are quite 
a few genotyping approaches that are solely dependent on hybridization, 
including GeneChip Mapping Array (Khrapko et al., 1991; Southern 1992; 
Guo et al., 1994; Kennedy et al., 2003).  Indeed, TaqMan (Applied 
Biosystems) also largely depends on allele-specific hybridization (Livak 1999), 
even though it is often classified into other category.  However, the 
discrimination power of allele-specific hybridization alone is very limited.  
Affymetrix addressed this problem with the use of redundant probes, which 
means that multiple different oligonucleotide probes are designed to 
interrogate the same SNP (Lipshutz et al., 1999).  For example, each SNP is 
represented by about 40 probes on GeneChip Mapping Array. 
 
b. Primer extension 
Genotyping SNPs through primer extension is a simulation of the in vivo 
process of polymerase-mediated DNA synthesis during cell division.  The 
greatest benefit of this strategy can be seen in that accurate and specific result 
can be obtained due to the high-fidelity feature of DNA polymerases.  Many 
DNA polymerases also have 3' exonuclease activities, which further ensure 
incorporation of proper nucleotides when the primers perfectly anneal just 5' 
or exactly at the SNP site on target DNA.  The allele discrimination power of 
primer extension was found at least nine times higher than that of 
hybridization (Pastinen et al., 1997).  Another frequently overlooked 
advantage of primer extension is that the design of primers is very 
straightforward. 
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Numerous forms of primer extensions are currently in employment in the 
analysis of SNPs.  For simplicity, they can be divided into two categories 
according to the nucleotides in use, i.e., single-base extension (SBE) by 
dideoxynucleotides (ddNTPs) and multiple-base extension (MBE) by 
deoxynucleotides (dNTPs).  SBE is often referred to minisequencing, but it is 
not appropriate if single-base extension is achieved with dNTPs.  For example, 
the gap-fill reaction of MIP assay is essentially single-base extension with 
dNTPs followed by ligation (Hardenbol et al., 2003).  Minisequencing is 
usually performed with fluorescently labeled ddNTPs, which facilitates direct 
allele identification of the target DNA.  If unlabeled ddNTPs are used, the 
extended products can be resolved alternatively by mass spectrometry (Griffin 
et al., 2000). 
If two primers differing only in the last base at the 3' hybridize to proper 
template, the primer with 3' perfectly matched base will be extended by DNA 
polymerases at a much higher efficiency (102-104) than the primer with 3' 
mismatched base.  To take advantage of this feature, allele-specific primer 
extension methods have been developed to analyze SNPs.  If an additional 
primer is introduced, the locus with SNP can be amplified exponentially, 
which is termed allele-specific PCR (Myakishev et al., 2001).  Compared to 
minisequencing, allele-specific primer extension has lower discrimination 
power, but it allows both single-base and multiple-base extensions.  One 
obvious benefit of MBE over SBE is that it permits incorporation of multiple 
fluorescently labeled dNTPs (Pastinen et al., 2000; Gunderson et al., 2005).  
Indeed, SBE and MBE can even be combined into a single reaction, for which 
an in-depth review is given later through the hME assay (Storm et al., 2003). 
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c. Ligation 
Ligase is mainly responsible for repairing DNA nicks by joining two adjacent 
oligonucleotides at the junction if they hybridize perfectly to the DNA 
template.  This function of DNA ligase has been fully utilized to genotype 
SNPs through a few schemes.  A typical method to interrogate SNPs by ligase 
is achieved through two allele-specific oligonucleotides and one common 
oligonucleotide, which is termed oligonucleotide ligation assay (OLA) 
(Landegren et al., 1988).  Some commercial genotyping platforms like SNPlex 
are entirely based on this strategy.  Genotyping by OLA is very specific and 
accurate.  gDNA can be potentially genotyped by other ligase-mediated 
technologies such as ligase chain reaction (LCR) (Barany 1991) and padlock 
probes (Nilsson et al., 2002; Baner et al., 2003; Landegren et al., 2004), by 
which prior PCR amplification of target can be completely eliminated.  An 
ingenious  modification of the typical ligation reaction is the introduction of 
SBE prior to ligation (Hardenbol et al., 2003).  By such way, only two 
oligonucleotides are required to interrogate each SNP.  More importantly, the 
incoming nucleotide (SNP) will be double-checked by both polymerase and 
ligase. 
 
d. Nuclease cleavage 
SNP analysis through allele-specific cleavage by DNA nucleases has been in 
use for quite a long time.  The first generation of genetic marker map was 
indeed obtained by PCR-restriction fragment length polymorphism (PCR-
RFLP) strategy, which utilizes restriction endonucleases to recognize and 
cleave allele-specific sequences with high specificity (Weber 1990).  However, 
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both cleavage and separation by gel electrophoresis are very time consuming 
and labor intensive, and PCR-RFLP is not amenable to multiplexing.  
Moreover, certain sequences with SNPs cannot be cleaved by appropriate 
restriction endonucleases. 
The intrinsic 5' nuclease activity of Taq DNA polymerase has also been 
successfully utilized for SNPs analysis, as can be seen by TaqMan assay 
(Livak 1999).  In principle, both allele-specific probes carrying one reporter 
and one quencher at either end can hybridize to DNA template under PCR 
condition.  During chain elongation, the perfectly matched probe will be 
degraded by Taq DNA polymerase, thus releasing the reporter from quencher 
to emit fluorescence.  In contrast, the mismatched probe will remain intact and 
the reporter is still in the quencher’s proximity.  This approach is very robust 
because SNPs can be genotyped in a closed-tube, but its allele discrimination 
power is limited because it depends largely on the different hybridization 
efficiencies between perfectly matched probe and mismatched probe.  
Moreover, probes with dual modifications are costly.  This limitation was 
recently addressed by the introduction of universal reporter with dual labels 
(Rickert et al., 2004).  TaqMan is also limited in its low compatibility with  
highly multiplexed applications. 
Invader assay is the most powerful nuclease-mediated genotyping method, for 
which a comprehensive discussion is given later. 
 
iii) Allele detection 
Numerous assay formats are currently available to seperate and detect alleles 
because many properties of the oligonucleotides and some by-products after 
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allele-discrimination reactions are detectable.  Allele discrimination products may 
differ in size and mass.  For example, cleavage products by RFLP are separated by 
gel because of the different mobilities conferred by the size.  Similary, detection 
of SNPlex is accomplished through capillary electrophoresis technology, which 
also depends on the mobility of allele discrimination product.  The application of 
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry to detect alleles is based on the fact that different alleles differ in the 
mass, as can be seen by hME assay.  Pyrosequencing technology takes advantage 
of pyrophosphate produced from primer extension reaction to analyze SNPs 
(Ronaghi et al., 1996).  The most straightforward approach for allele identification 
is achieved by capturing the signals from the fluorescent lables, which is widely 
used by many commercial platforms such as GeneChip Mapping Array and 
GoldenGate.  Other effects such as fluorescence resonance energy transfer (FRET) 
(Livak 1999; Olivier 2005) and fluorescence polarization (Kwok, 2002) have also 
been utilized in the detection of allele-specific products. 
It is true that the choice of allele detection format is largely determined by the 
biochemistry of allele discrimination, but detection device is often the bottleneck 
of the whole assay for some technologies.  For example, minisequencing products 
can be accurately identified by MALDI-TOF, but MBE and ligation products of 
GoldenGate assay are not suitable to be detected similarly.  On the other hand, 
minisequencing can be carried out in a highly multiplexed format, but detection 
by MALDI-TOF can only guarantee accurate analysis of oligonucleotides less 
than 40 bases in length (Kaetzke et al., 2002).  For this reason, hME assay permits 
only 24-plex at the moment.  The multiplexing level of SNPlex (48-plex) is also 
largely limited by capillary electrophoresis. 
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iv) Examples of genotyping technologies 
 
a. Homogenous MassEXTEND assay (Sequenom) 
Homogenous MassEXTEND assay (hME) is a typical primer extension-based 
genotyping technology.  The uniqueness of hME assay can be seen in two 
aspects.  First, allele discrimination is achieved simultaneously by 
minisequening and MBE.  Second, the detection of different alleles is based on 
the masses of the extended primers by MALDI-TOF mass spectromety. 
Typically, three procedures are carried out to analyze SNPs by MALDI-TOF 
(Griffin et al., 2000; Pusch et al., 2002; Blondal et al., 2003; Storm et al., 
2003).  First, locus-specific PCR is performed to amplify DNA regions 
containing SNPs of interest.  Following this, redundant dNTPs will be 
digested by shrimp alkaline phosphatase (SAP) to prevent their interference 
with subsequent primer extension reaction.  Secondly, a common 
MassEXTEND primer and a cocktail (typically containing one ddNTP and 
three dNTPs) are introduced to initiate primer extension reaction.  Depending 
on the sequence downstream the SNP site and which ddNTP is present, the 
primer will be extended by 1–4 bases.  As a result, the extention products of 
different alleles and the intact primer differ from each other in length.  This 
way, allele discrimination is accomplished.  Thirdly, following the removal of 
extraneous salts by resin, extension products are analyzed by MALDI-TOF to 
determine the genotypes by mass. 
The hME assay is very easy to operate and it allows multiple SNPs to be 
analyzed in a single reaction.  As allele discrimination is mediated by high-
fidelity DNA polymerase, and genotype calling is fulfilled in real time by 
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MassArray software, highly reproducible results can be obtained.  
Significantly, detection of alleles is dependent on their masses, thus 
eliminating the requirement of fluorescently labeled ddNTP or dNTPs for 
primer extension reaction.  However, mass-dependent detection by MALDI-
TOF also determines that the multiplexing capacity of hME assay is limited 
(Ross et al., 1998; Nordhoff et al., 2000; Kaetzke et al., 2002).  Even though 
an advanced version of hME assay called iPLEX has been launched recently, 
it still permits maximum 24 SNPs to be interrogated simultaneously 
(http://www.sequenom.com).  The typical hME assay is also limited by the 
requirement of locus-specific PCR amplifications with multiple primers.  If 
the noise signals from unextended primers are addressed, hME assay can be 
further improved.  Moreover, its cost per genotype is relatively higher than 
other platforms.  Nevertheless, hME assay is a wise choice if moderate SNPs 
are studied in a large number of samples. 
 
b. SNPlex (Applied Biosystems) 
SNPlex genotyping system depends exclusively on oligonucleotide ligation 
assay (OLA) to discriminate alleles, and the detection of different alleles is 
achieved by capillary electrophoresis technology.  An all-inclusive review on 
both SNPlex and TaqMan technologies was published recently (De la Vega et 
al., 2005). 
Like conventional OLA, SNPlex requires two allele-specific oligonucleotides 
(ASOs) and one locus-specific oligonucleotide (LSO) for allele discrimination 
reaction.  However, both ASOs of SNPlex are tagged with a unique ZipCode 
sequence, and the LSO is tagged with a universal PCR primer sequence.  In 
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order to introduce another PCR primer sequence, two universal allele-specific 
oligonucleotide linkers (ASO-linker) are designed.  If a particular ASO-linker 
and its matching ASO are successfully ligated to proper LSO and its matching 
LSO-linker, both universal PCR primer sequences and the unique ZipCode 
sequence will be joined to make up a full-length oligonucleotide which also 
contains the gene-specific sequences from both ASO and LSO.  Thus, allele 
discrimination is accomplished.  If a large number of SNPs are genotyped in 
this way, all full-length oligonucleotides can be subsequently amplified by a 
common PCR primer pair.  One of the universal primer is biotinylated so that 
only one strand of the amplified full-length amplicons can be captured by 
streptavidin-coated plates.  The main function of turning double-stranded 
amplicons into single-stranded is to make subsequent entrapment of ZipChute 
probes more efficient.  ZipChute probes are fluorescently labeled, and they are 
composed of a universal sequence which is complementary to the allele-
specific ZipCode sequence of the captured amplicons and a unique modifier 
which determines the mobility rate during electrophoresis.  After being 
released from the plates, ZipChute probes can be detected by Applied 
Biosystems 3730 DNA Analyzer. 
This ligation-based technology does not require locus-specific amplification 
by PCR, and it permits 48 SNPs to be genotyped simultaneously.  As the 
detection of different alleles is based on a pair of unique and universal probes 
with fluorescent label, it can be easily adapted to any fine-mapping studies 
with custom SNPs.  Significantly, seperation and detection carried out by 
capillary electrophoresis instruments is also very advantageous because they 
are widely available.  Among all high-throughput technologies, however, 
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SNPlex might be the most complicated one because it involves eight steps to 
discriminate and detect alleles (De la Vega et al., 2005).  For each SNP, 
moreover, eight oligonucleotides are required, including three gene-specific 
probes, three universal hairpin-like linkers and two fluorescently labeled 
probes.  Other than ligase, many other enzymes are also involved, such as 
kinase, exonuclease I, λ-exonuclease and DNA polymerase.  Hence, SNPlex 
can be improved in many ways, including its multiplexing level.  As the 
workflow of SNPlex is largely automated, however, it is suitable for moderate 
association studies of candidate genes or fine-mapping of custom SNPs on a 
larger sample size. 
 
c. Invader assay (ThirdWave) 
Invader assay requires three oligonucleotides for each SNP, i.e., one invasive 
probe and two allele-specific signal probes.  The invasive probe is 
complementary to the upstream region of gDNA except the last base (SNP 
site), which can be any nucleotide.  The signal probes are composed of a gene-
specific sequence and a universal flap, and they differ from each other by the 
SNP site.  The invasive and signal probes overlap by one base at the SNP site.  
To minimize background signal, the 3' ends of the signal probes are usually 
blocked with an amino group (Kwiatkowski et al., 1999; Lyamichev et al., 
1999; Hall et al., 2000). 
A typical Invader assay contains primary and secondary reactions (de Arruda 
et al., 2002; Lyamichev et al., 2003).  During primary reaction, when locus-
specific sequence of the signal probe perfectly matches gDNA, the probe will 
be cleaved by structure-specific 5' nuclease like Cleavase (ThirdWave) to 
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release its 5' universal flap.  As this reaction is carried out at a temperature 
similar to the melting temperature of the signal probes, cleaved signal probes 
will be replaced with intact ones to initiate many rounds of cleavage, thus 
producing multiple flaps.  If the signal probe does not match gDNA, its 5' flap 
cannot be released.  Thus, the primary reaction has two functions, allele 
discrimination and flap generation.  The flaps will serve as invasive probes in 
the secondary reaction, during which the flap will hybridize to a hairpin-like 
FRET cassette.  Consequently, the FRET cassette will be cleaved.  As the 
cassette contains a reporter and a quencher in close proximity, cleavage will 
release the reporter from the quencher so that fluorescent signals can be 
produced.  Because this reaction also permits cleaved cassettes to be replaced 
by uncleaved ones, numerous FRET cassettes will be cleaved by one copy of 
5' flap to release many reporters into the solution. 
In essence, Invader technology is a signal amplification approach which 
presents a few advantages over other genotyping methods.  For example, 
gDNA can be potentially genotyped without prior PCR amplification.  As both 
reactions are carried out under isothermal conditions, no dedicated and 
expensive instruments are required.  Moreover, it can be easily automated 
because it is a homogeneous assay.  To some extent, Invader assay is a high-
throughput approach because it allows analysis of a large number of samples 
per day.  However, one main limitation of this technology is that it is not 
amenable to be highly multiplexed.  Invader assay was recently adapted to 
solid supports to analyze multiple SNPs in a multiplexed manner, but it has yet 
to be promising for wide use in biomedical studies (Wilkins Stevens et al., 
2001; Stevens et al., 2003; Olivier, 2005). 
 21
1.3 Genotyping SNPs by microarray technology 
Despite the fact that numerous genotyping technologies have been successfully 
developed and widely applied in many association studies during the last decade, 
none of them have satisfactorily fulfilled the call for high-throughput genotyping until 
the introduction of microarray technology, which promises to analyze hundreds of 
thousands of SNPs simultaneously on a tiny solid support.  In 1992, an allele-specific 
oligonucleotide hybridization array was successfully developed for SNP discovery 
and detection (Southern 1992). 
 
i) Features of microarray 
In terms of the mechanisms of the three main events involved in SNP genotyping 
(target amplification, allele discrimination and detection), microarray technology 
differs little from traditional methodologies.  In essence, microarray is just a very 
powerful platform which aligns millions of probes to facilitate accurate sorting of 
hundreds of thousands of SNPs through hybridization.  In this sense, it is 
appropriate to describe the replacement of traditional approaches with microarray-
based ones as a simple shift of “from gel to chip”.  However, it is this shift that 
makes many previously impossible tasks possible, such as genome-wide mapping. 
For example, DNA target is usually prepared through multiple locus-specific PCR 
by most traditional methods.  For one reason, only a limited number of SNPs are 
genotyped in large populations by most case-control studies.  In this situation, 
locus-specific PCR is well-suited for target preparation.  On the other hand, allele 
detection by traditional methods such as gel electrophoresis usually require a large 
amount of amplicons.  Instead, microarray is potentially able to analyze a large 
number SNPs as mentioned above.  In order to provide corresponding number of 
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targets more efficiently for downstream, highly multiplexed detection by 
microarray, universal PCR is frequently employed.  Although locus-specific PCR 
is still possible, it can be very time-consuming and labor-intensive since many 
locus-specific PCR have to be carried out seperately.  Undoubtedly, the last 
decade has also witnessed the emergence of a few new approaches to prepare 
targets.  For instance, some whole genome amplification methods can produce 
sufficient targets from very little gDNA for subsequent analysis, thus completely 
eliminating the barriers of PCR. 
Like traditional methods, allele discrimination by microarray-based systems is 
also fundamentally based on allele-specific hybridization, high-fidelity 
polymerase-mediated primer extension or ligase-mediated reaction.  The main 
differences are often seen in how these reactions are carried out.  For instance, 
allele discrimination is traditionally performed after the DNA target is amplified.  
Instead, many commercial microarry platforms run these reactions in the reverse 
order, as in the cases of GoldenGate and MIP technologies.  Due to this simple 
shift of the reaction order, preparation of multiple targets is greatly simplified in 
the form of a universal PCR instead of multiple locus-specific ones.  Compared to 
traditional methods, moreover, allele discrimination by microarray-based ones is 
often carried out in a highly multiplexed manner and during this event, universal 
PCR primer sequences are introduced to facilitate subsequent target preparation.  
Frequently, another universal sequence is also introduced at this stage.  The 
purpose of doing this will be discussed shortly. 
The greatest advantages of microarry technology over conventional ones are seen 
in its robust and efficient separation and detection of different alleles.  With the 
use of a light-directed chemical process termed photolithography, oligonucleotide 
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probes (typically 25 bases in length) can be chemically synthesized at specific 
locations at a density of over 100 million.  In this way, millions of different probes 
can be manufactured on a small glass slide called GeneChip.  Significantly, each 
probe on the array is addressable, which is crucial for accurate genotyping (Fodor 
et al., 1991).  GeneChip provides the most powerful platform obtainable thus far 
for any nucleic acids-based studies, and its contribution to biomedical studies can 
never be underscored.  With a given number of GeneChip arrays, the whole 
genome can be accessed to the largest degree via hybridization.  As mentioned 
above, another important feature of many microarray methods is the introduction 
of universal sequence which is inserted into allele-/SNP-specific 
oligonucleotide(s).  This unique sequence serves as a surrogate of a particular 
allele or SNP, and detection of such sequence directly signifies the presence of the 
corresponding allele or SNP.  It has different names under different platforms, 
such as “Address” (GoldenGate), “ZipCode and ZipChute” (SNPlex) and “Tag” 
(MIP).  The greatest benefits of introducing surrogate sequence can be seen in two 
aspects.  First, it allows multiple SNPs to be interrogated through a universal array 
in a highly flexible manner.  This means that if a generic array is fabricated, it can 
be applied to any association studies with different SNPs.  Second, genotyping 
through surrogate sequence can be more accurate and specific because the 
genomic sequence complexity is largely reduced.  Unfortunately, this advantage 
of surrogate sequence has not been well recognized.  Microarray technology can 
never be so successful without the introduction of fluorescence for detection.  
Traditional gel assay requires several picomoles of amplicons for allele detection.  
Through fluorescence, however, microarray enables detection of attomoles to 
femtomoles of DNA targets.  Hence, the detection power is increased by at least 
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three orders, which greatly facilitates genotyping of enormous SNPs 
simultaneously. 
 
ii) Workflow of microarray 
Typically, genotyping by microarray technology consists of three consecutive 
events: array manufacture, arrayed hybridization and signal reading/data analysis. 
 
a. Array manufacture 
Microarray is usually fabricated by either in situ synthesis or immobilization 
of pre-synthesized oligonucleotides.  In situ synthesis is well known as the 
Affymetrix approach, which directly synthesizes oligonucleotides on a small 
glass slide through photolithography (Fodor et al., 1991).  This process is 
highly automated and permits production of many arrays with consistent and 
reproducible features.  However, this kind of array is still the most expensive 
one in the market, even though its price has been reduced substantially.  
Despite the fact that custom array can be easily manufactured due to its 
flexibility, it is still not cost-effective if an array with much fewer features is 
needed. 
Alternatively, pre-synthesized probes can be immobilized on glass slides by 
either contact printing or inkjet dispensing (Hacia et al., 1998; Hacia 1999).  
Compared to in situ synthesis, the advantages of probe immobilization can be 
seen in its ease of prototyping, rapid implementation, versatility and low cost.  
Prior to being immobilized, however, each probe has to be chemically 
synthesized and modified with anchors such as amino group.  If many probes 
are required, the cost can also be very high.  As many factors (e.g., incubation, 
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humidity and washing) are difficult to control, arrays prepared by 
immobilization are not very consistent. 
Depending on the nature and size of the probes positioned on the glass slide, 
microarray can be simply divided into cDNA array and oligonucleotide array.  
The cDNA array is often used to monitor gene expression, but oligonucleotide 
array can find wide applications in both gene expression and genotyping 
studies. 
 
b. Arrayed hybridization 
In essence, the concept of microarray technology is the same as that of 
Southern blotting, which investigates genetic information through 
hybridization between complementary oligonucleotides. 
It is true that the power of allele discrimination by hybridization alone is 
limited.  Without hybridization, however, high-throughput genotyping by 
microarray-based platforms is not possible.  Microarray technologies depend 
solely on hybridization to sort a huge number of DNA targets which bear 
specific sequences complementary to their corresponding probes on the chip.  
Usually, the analyte may contain millions of different DNA targets of different 
sizes.  Through hybridization alone, these DNA targets can be efficiently and 
accurately separated from each other with probes that are only 25 nucleotides 
in length (GeneChip).  It is no doubt that microarray provides the most 
powerful biological sifter that cannot be surpassed, but the successful 
application of microarray technology to analyze genetic information is made 
possible by its underlying principle, hybridization. 
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It should be highlighted that sorting by surrogate sequence has also greatly 
improved the performance of microarray-based genotyping platforms.  By 
such a method, genomic sequence complexity of the analyte is significantly 
reduced, thus facilitating efficient and accurate hybridization. 
Besides sorting, hybridization is also utilized to discriminate alleles by 
GeneChip Mapping Array.  To overcome its limited power in the 
identification of single base mismatches, Affymetrix designs redundant probes 
to interrogate each SNP so that the specificity is greatly improved. 
 
c. Signal reading and data analysis 
Allele detection by microarray technologies is usually achieved through the 
capturing of the fluorescence signals by confocal scanners.  These approaches 
are mainly based on either one-color or four-color detection strategy.  Usually, 
more probes or arrays are required if one-color strategy is in use.  By the four-
color approach, one probe and one array are sufficient to interrogate all 
genotypes of each SNP.  For example, one-color is employed by GeneChip 
Mapping Array, which requires allele-specific probes for each SNP (Kennedy 
et al., 2003).  MIP technology was first reported to call all genotypes by one-
color detection via four separate arrays (Hardenbol et al., 2003).  To overcome 
the variations between arrays, a four-color version was recently reported 
(Hardenbol et al., 2005). 
Analysis of the signals from microarray-based genotyping technologies is 
always accomplished by some bioinformatic tools, which ensures accurate and 
efficient genotype calling. 
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iii) Array-based genotyping platforms 
At present, several commercial oligonucleotide array-based platforms are widely 
in use and they are mainly based on allele-specific hybridization, primer 
extension, ligation or the latter two. 
 
a. GeneChip Mapping Array (Affymetrix) 
GeneChip Mapping Array is the most successful hybridization-based 
genotyping platform which claims to be able to generate more than 100,000 
genotypes by a set of two arrays (Kennedy et al., 2003; Matsuzaki et al., 2004; 
Matsuzaki et al., 2004).  One distinctive feature of this innovative technology 
can be seen in that the whole genome is amplified by a universal PCR with 
only one generic primer.  The assay begins with random digestion of gDNA 
by restriction enzymes (XbaI or HindIII) to generate fragments of different 
sizes.  Following this, adaptors are ligated to all DNA fragments, regardless of 
their sizes.  Subsequently, PCR is performed with only one generic primer 
which recognizes the adaptor sequence.  Although all fragments with adaptor 
sequences are potentially able to be amplified, those falling between 250bp 
and 2,000bp are preferred under controlled PCR conditions.  The amplicons 
are then fragmented and end-labeled with biotinylated ddATP before they are 
injected into the microarray cartridge for hybridization to the probes.  Finally, 
the array is stained and scanned to acquire fluorescence signals. 
The main procedures and reactions of this genotyping technology are 
represented schematically in Figure 1.1 (adapted from Kennedy et al., 2003).  
There are a few advantages of this assay.  First, only 250 ng of gDNA is 
required from a given sample for almost genome-wide genotyping.  Secondly, 
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only a single primer is required to amplify all fragments of interest by a 
universal PCR.  Thirdly, all procedures are automated and 100,000 genotypes 
can be called with an accuracy of more than 95%. 
Since this technology is designed for genome-wide association studies, all 
probes on the chip are gene-specific sequences.  Thus, it is not a wise choice 
for linkage studies with small number of SNPs or with SNPs that are not 
covered by the chip.  Currently, each SNP is interrogated by about 40 different 
probes on the array.  If this problem is addressed, the throughput per array can 
be significantly increased.  Following hybridization, staining is required to 
label DNA fragments because they are previously end-labeled with 
biotinylated ddATP.  If these fragments are directly end-labeled with 
fluorescently labeled ddNTP or dNTP, the assay can be simplified and its 
sensitivity may be improved.  Moreover, sophisticated algorithm is 
indispensable for the analysis of the enormous amount of data obtained (Liu et 
al., 2003). 
To expand its applications, Affymetrix has recently acquired ParAllele 
Bioscience and thus its proprietary molecular inversion probe (MIP) 
technology.  The current version of MIP allows 12,000 SNPs to be genotyped 
simultaneously (Hardenbol et al., 2005).  Once integrated with Affymetrix’s 
universal tag array, MIP technology will offer scientists with unprecedented 
access to any area of the genome. 
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Figure 1.1 Schematic representation of Affymetrix’s GeneChip Mapping Array.  
Genomic DNA is fragmented by RE (1) so that a common adaptor sequence can be 
introduced by ligation (2).  Thus, all fragments with such adaptor can be amplified by 
PCR with a common primer (3).  After another fragmentation procedure, DNA 
fragments are end-labelled with biotin-dATP (4).  Finally, hybridization, staining and 
scanning are performed (5).  
 
b. GoldenGate assay (Illumina) 
The GoldenGate assay comprises three main events (Figure 1.2) (adapted from 
Shen et al., 2005).  The first event includes two reactions, primer extension 
and ligation.  Allele discrimination is achieved through polymerase-mediated 
primer extension.  For each SNP, two allele-specific oligonucleotides (ASOs) 
and a common locus-specific oligonucleotide (LSO) are required.  Besides the 







sequence for subsequent PCR amplification.  Insertion of an additional unique 
address sequence into LSO is to enable ligated and amplified oligonucleotides 
to hybridize to probes on Sentrix Array Matrix or BeadChip.  As LSO 
hybridizes a few bases downstream from the SNP site, multiple nucleotides 
will be incorporated into appropriate ASO perfectly matching gDNA.  If the 
last base is not complementary to gDNA, such ASO cannot be extended.  
Following this, extended ASO will be joined with downstream LSO by DNA 
ligase.  Consequently, full-length ASO-LSO oligonucleotides (containing two 
universal primer sequences, two locus-specific sequences, one unique address 
sequence and a few gene-specific bases) is generated.  The second event is to 
amplify full-length ASO-LSO oligonucleotides with three universal PCR 
primers, Cyanine 3-P1, Cyanine 5-P2 and unlabeled P3.  Thirdly, Cy3- and/or 
Cy5- labeled amplicons hybridize to corresponding probes on Sentrix Array 
Matrix or BeadChip via the unique address sequences so that fluorescence can 
be detected by BeadArray Reader for subsequent genotype calling. 
Like GeneChip Mapping Array, only 250ng of gDNA is required by 
GoldenGate to interrogate up to 1,536 SNPs in a single reaction.  In terms of 
allele discrimination, GoldenGate is essentially based on polymerase-mediated 
primer extension, regardless of the use of ligase.  The checkpoint of this assay 
is polymerase-mediated allele-specific primer extension.  Only if the last 
incorporated nucleotide matches the gDNA, extended ASO will be ligated 
with LSO.  In this sense, allele discrimination by ligase is limited.  Thus, the 
main function of ligase is to ligate extended ASO and LSO so that universal 




Figure 1.2 Schematic representation of ILLUMINA’s GoldGate assay.  Allele-
specific primer extension and ligation are carried out to amplifiy genomic DNA (1), 
followed by a universal PCR with two upstream primers (Cy3- or Cy5-labelled) to 
generate sufficient targets (2) for hybridization, which is dependent on the unique 
sequence previously introduced in the downstream LSO (3).  
 
Alternatively, if LSO is designed to hybridize exactly next to the SNP site, 
ligation can occur directly when appropriate ASO and LSO are present.  As 
such, both allele discrimination and generation of full-length oligonucleotides 
can be accomplished via ligation alone, thus eliminating the use of 
polymerase.  Indeed, no obvious advantage can be seen from using primer 
extension and ligation to discriminate alleles over ligation alone, if polymerase 





GoldenGate permits 1,536 SNPs to be interrogated in a single reaction.  
Compared to MIP (12,000-plex), the multiplexing level of GoldenGate is 
relatively lower.  This can be partially attributed to the requirement of three 
oligonucleotides for each SNP.  Since the locus-specific sequences of ASOs 
differ by only one nucleotide, they may compete for hybridization to gDNA, 
which in return prevent efficient extension of the perfectly matched ASO.  If a 
common upstream oligonucleotide and a downstream LSO are designed to 
hybridize to the regions exactly before and after the SNP site, the single-base 
gap can be filled by primer extension and ligation.  In this manner, it is 
expected that the multiplexing level can be increased as each SNP requires 
only two oligonucleotides.  More importantly, base calling can be improved 
because the discrimination can be double-checked by both polymerase and 
ligase. 
 
c. Molecular inversion probe (ParAllele) 
As another enzyme-dependent genotyping technology, MIP is very different 
because its allele discrimination is achieved by both polymerase-mediated 
primer extension and ligase-mediated ligation.  As such, if misincorporation 
by primer extension occurs, ligation cannot proceed. 
Originated from padlock probe (Nilsson et al., 1994; Nilsson et al., 2002), 
MIP probe is composed of seven regions, including two gene-specific 
sequences, two primer sequences common to all probes, two cleavage sites for 
all probes and one tag sequence specific to each SNP (Hardenbol et al., 2003).   
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Figure 1.3 Overview of molecular inversion probe (MIP) technology.  Allele-specific 
primer is circularized only if corresponding dNTP is present (1).  In this case, the 
primer for G allele is closed only in the tube with dCTP.  Subsequently, all liner DNA 
(including genomic DNA and primer) will be digested by Exo I and III (2).  
Following this, a specific restriction enzyme is introduced to cleave the circular probe 
(3) so that it can be amplified by a universal PCR (4).  Finally, hybridization and 
scanning are performed for base calling (5).  
 
Briefly, MIP assay can be divided into 4 steps (Hardenbol et al., 2005).  First, 
MIP probe hybridizes to a particular site of gDNA through its gene-specific 
sequences to form a circular structure with a single-base gap for dATP, dGTP, 
dCTP or dTTP.  If the corresponding site of gDNA is G (Figure 1.3, adapted 
from Hardenbol et al., 2003 and Hardenbol et al., 2005), MIP probe will be 
extended with a single dCTP by DNA polymerase and subsequently 
circularized covalently by ligase under controlled conditions, a process called 







gDNA and linear MIP probes will be digested.  Secondly, ligated MIP probes 
will be cleaved through a common site between the universal PCR primer 
sequences.  Consequently, the primer sequences are seperated from each other 
by gene-specific sequences and the specific tag sequence.  Thirdly, following 
this, inverted MIP probes are amplified with the common primer sequences by 
a universal PCR.  Finally, after treatment with a restriction endonuclease to 
release the gene-specific sequences, all reaction products from four tubes are 
pooled and loaded on Affymetrix’s GenFlex Tag Array to perform 
hybridization.  Only  fluorescently labeled tag sequence of MIP probes can be 
detected. 
As only one probe is required for each SNP, MIP permits highly multiplexing 
to genotype 12,000 SNPs in a single reaction with a concordance rate higher 
than 99% (Hardenbol et al., 2005).  Allele detection of MIP is achieved 
through universal tag sequences, thus it is very flexible and can be easily 
adapted to any custom SNP studies.  This somehow explains why Affymetrix 
paid $120 million to acquire ParAllele because the integration of MIP into its 
own universal tag array is potentially able to allow scientists to conduct 
virtually any experiments. 
However, one limitation of MIP is the requirement of a large number of 
probes.  Originally, MIP required four arrays for genotype calling due to its 
one-color strategy (Hardenbol et al., 2003).  To address this problem, an 
intermediate two-color version was developed.  Under such strategy, A/C and 
G/T were labeled with different fluorophores.  Before hybridization, two pools 
were prepared (one for A/G, the other  for C/T).  In this manner, only two 
arrays are required, but feature-to-feature variations between arrays are still 
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present.  The current version of MIP uses a four-color strategy, by which each 
allele is labeled differentially with a spectrally distinct fluorophore.  
Consequently, all reaction products can be pooled together before 
hybridization on a single array.  As such, the problematic array-to-array 
variations of the first two versions of MIP is completely solved. 
 
1.4 Objectives of the present studies 
In this thesis, my main aim was to evaluate and develop methodologies for highly 
multiplexed genotyping of single nucleotide polymorphisms using microarray 
technology. 
The first study (Chapter 2) was an effort to adapt polymerase-mediated 
minisequencing to solid-phase platform (microarray). 
In the second study (Chapter 3), I intended to develop a simple but versatile 
genotyping platform by integrating a novel two-color strategy with universal tag/anti-
tag system and liquid-phase minisequencing. 
The third study (Chapter 4) was an attempt to explore one unusual property of TdT, 
i.e., catalysis of oligonucleotide elongation in DNA template-independent manner, to 
develop a versatile tool capable of array fabrication and signal introduction for both 
genotyping and gene expression studies. 
During the third study, more unusual features of TdT were observed, which thus 
became the topic of the fourth study (Chapter 5). 
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CHAPTER 2 DEVELOPMENT OF A CHIP-BASED PLATFORM FOR 
SIMULTANEOUS GENOTYPING OF 20 SNPS IN CORONARY ARTERY 
DISEASE CANDIDATE GENES 
 
2.1 Introduction 
The most common genetic variations in human genome are in the form of single 
nucleotide polymorphisms (SNPs).  SNPs are defined as single-base substitutions, 
insertions or deletions in genomic DNA at a frequency of 1% or higher.  They  
represent about 90% of all genetic variations and  are estimated to occur at an average 
frequency of one per thousand nucleotides (Lindroos et al., 2002).  It is widely 
believed that SNPs are associated with many common diseases such as Alzheimer’s, 
Parkinson’s and cardiovascular diseases.  In addition, SNPs will enable personalized 
drugs to become a reality in the field of pharmacogenomics.  The significance of 
SNPs is also highlighted by the efforts to develop the third generation of genetic 
marker map with SNPs, which will substitute restriction fragment length 
polymorphism map (RFLP, first generation) and microsatellite map (second 
generation) (Weber 1990; Dib et al., 1996; Wang et al., 1998).  With rapid 
accumulation of knowledge on the association between SNPs and multi-factorial 
diseases with complex inheritance patterns, the diagnosis, prevention, treatment of 
diseases and drug development will enter a new stage (Zhang et al., 1997). 
Thus far, a number of molecular technologies have come into use for rapid and 
accurate genotyping of SNPs (Shi, 2001).  Due to the strong and specific base pairing 
feature of complementary DNA, DNA molecules themselves can serve as the ideal 
reagents to identify DNA sequences of interest.  Based on this, some hybridization-
based  methods have been successfully developed for SNP genotyping (Khrapko et 
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al., 1991; Southern 1992).  Unfortunately, the power of allele discrimination by 
hybridization alone is limited because it depends solely on the thermal stabilities of 
mismatched and perfectly matched hybrids.  Alternatively, more genotyping 
approaches utilizes high-fidelity enzymes to access SNPs such as DNA polymerase 
and ligase.  DNA polymerase-mediated genotyping methods are typically exemplified 
by minisequencing, by which the primers annealing just 5' to the nucleotide of interest 
on target DNA are extended with one of the four ddNTPs (Jalanko et al., 1992).  
Another widely used method is called oligonucleotide ligation assay (OLA), which is 
mediated by DNA ligase (Landegren et al., 1988).  Genotyping SNPs by these 
methods have been proven to be very accurate and highly reproducible.  However, 
they are usually carried out in liquid-phase, which does not allow genotyping of 
multiple SNPs simultaneously.  With the advent of microarray technology, more 
efforts have been shifted towards development of solid-phase based genotyping 
approaches as they are promising to interrogate hundreds of thousands of SNPs 
simultaneously.  This is very important for rapid identification of disease-susceptible 
SNPs by large-scale and genome-wide association studies. 
This study is one of such efforts which attempts to adapt minisequencing to solid 
platform in the hope that many SNPs in candidate genes of coronary artery disease 
can be simultaneously genotyped for risk assessment. 
 
2.2 Materials and methods 
 
Amplification of genomic DNA 
Genomic DNA was isolated from peripheral blood leukocytes of 10 subjects by 
standard phenol-chloroform method (Kunkel et al., 1977) and the concentration was 
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estimated by ND-1000 Spectrophotometer.  Twenty SNPs were selected from some 
candidate genes associated with coronary artery disease previously studied by 
conventional methods in our group (Table 2.1).  Most of these SNPs had been 
previously reported (Chamberlain et al., 1989; Bujo et al., 1991; Evans et al., 1993; 
Suzuki et al., 1994; Valdenaire et al., 1995; Wang et al., 1995; Lane et al., 1996; 
Weiss et al., 1996; Henry et al., 1997; Wilson et al., 1997; Carmena-Ramon et al., 
1998; Cullen et al., 1998; Hibi et al., 1998; Sanghera et al., 1998; Grainger et al., 
1999; Dachet et al., 2000), only two SNPs (ELN422 and ELN290) were identified in 
our laboratory.  The primers were purchased from Alpha DNA (Canada) and 
dissolved to a concentration of 200µM (Table 2.1).  PCR amplification was set up in a 
total volume of 20µl in order to generate sufficient amplicons for both sequencing and 
RFLP reaction.  Typically, the mixture contained 0.2 units of DyNAzyme™ II DNA 
Polymerase (Finnzymes, Finland), 20pmols of primers, 2.5mM dNTPs and 50-100ng 
of genomic DNA.  PCR was performed in an automated thermal cycler (Biometra) 
with an initial denaturation at 95°C (5 min), followed by 15 cycles of 95°C (30 sec), 
63°C (1 min), 72°C (1 min) and another 20 cycles of 95°C (30 sec), 55°C (1 min), 
72°C (1 min).  The reaction was terminated after final extension at 72°C (10 min). 
 
Genotyping by sequencing 
The PCR products were purified using QIAquick PCR Purification Kit (Qiagen, USA).  
First, one volume of PCR solution was mixed with 5 volumes of PB buffer in a clean 
microcentrifuge tube.  This mixture was loaded into the QIAquick column provided 
for DNA binding, followed by centrifugation (14,000rpm, 2 min) to discard the flow-
through.  Subsequently, 0.75ml PE buffer was introduced to wash the column and 
centrifugation was repeated to remove the buffer.  To release DNA, 30 μl EB buffer
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Table 2.1 SNPs, restriction enzymes and PCR primers of this study 
PCR primers 
SNPs Restriction enzymes forward reverse 
ANGR T/G Dde I gagattgcatttctgtcagt ataatgtaagctcatccacc 
ApoAI-75 G/A 
ApoAI+83 C/T 
Msp I cagagctgatccttgaactcttaag ggacacctacccgtcaggaagagca 
ApoBgc C/T Apa I ataaggcatgtggtgttgaggcgc ccgtgcctggtgcaaacacacaag 
ApoBtz C/T EcoR I ctgagagaagtgtcttcgaaag ctcgaaaggaagtgtaatcac 
ApoE112  T/C Hha I ctgggcgcggacatggaggacgt gatggcgctgaggccgcgctcg 
ECE  C/T MspA1 I ggcctcatcaccgatcccca tctcgtcctcagccccttcc 
Eln422 G/A 
Eln290 T/C 
BstN I ggcctgggggaaatttacatcctc acattcaagcccgatctacagtcc 
ENOS G/T Mbo I catgaggctcagccccagaac ccagtcaatccctttggtgctc 
F13 C/T BsmF I ttgcctgtcattatctctgg gaaccacaccattgttagcttac 
FVIIT C/T Nci I gggagactccccaaatatcac acgcagccttggctttctctc 
GP3A  T/C Nci I tctgattgctggacttctctttg tctctccccgcaaagagtcc 
HFE63  C/G Dpn II acatggttaaggcctgttgc gccacatctggcttgaaatt 
LCAT C/G Msp I accatcagagacgaagggaaggg agggacgtcattcctctaagggac 
LPLPvu  C/T Pvu II atggcacccatgtgtaaggtg gtgaacttctgataacaatctc 
PAI-1 G/A BseL I cacagagagagtctggccacgt gcagccagccacgtgattgtctag 
PON2  C/G Dde I acatgcatgtacggtggtcttata gttaagttatcgcactttcatgcc 
TGFb509  C/T Bsu36 I cagactctagagactgtcag gtcaccagagaaagaggac 
TNFa G/A Eco130 I aataggttttgagggccatg tctggaggaagcggtagtgg 
Except two novel SNPs (ELN422 and ELN290) which were identified in our laboratory, all 
other SNPs had been previously reported. 
LCAT and PAI-1 were actually single-nucleotide insertions/deletions. 
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was added to the column’s membrane.  After incubation (2 min) and centrifugation, 
the flow-through was collected for downstream sequencing.  The sequencing reaction 
was carried out using BigDye™ Terminator Cycle Sequencing Ready Reaction Kit 
(ABI, USA).  Briefly, one microliter of purified PCR product, 3.2 pmols of primers, 
2µl of BigDye and 1µl of buffer were mixed and topped up with ddH2O to a 20µl 
cocktail.  This mixture was subjected to 25 cycles in an automated thermal cycler 
(Biometra), each cycle consisting of 95°C (10 sec), 50°C (5 sec) and 60°C (4 min). 
After precipitation with ethanol, 12µl of Hi-Di formamide was added into the reaction 
solution before being loaded into ABI 3100 sequencer. 
 
Genotyping by RFLP 
Typically, an aliquot of PCR products was digested with an appropriate restriction 
enzyme (Table 2.1) in a humidified incubator (37°C, overnight).  Subsequently, 
digestion products were separated by an agarose gel incorporated with ethidium 
bromide (0.2µg/ml) in 1xTBE buffer (89mM Tris base, 89mM boric acid and 
2mM EDTA).  Finally, fragments of different sizes were visualized on a UV 
transilluminator (Mighty Bright, Hoefer Scientific) and photographed by a Polaroid 
MP-4 camera system. 
 
Genotyping by chip-based minisequencing 
The probes to be immobilized were 15 to 20-mer gene-specific oligonucleotides tailed 
with a spacer (15dT) and an amino-linker at 5' ends (Table 2.2).  The immobilization 
was based on the Schiff's base reaction between amino and aldehyde molecules.  Prior 
to spotting, the probes were re-suspended with ArrayIt™ Micro-Spotting Solution 
(TeleChem, USA) in a 384-well plate (40µM).  They were spotted in quadruplicates 
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in a 2 X 2 format by PixSys7500 system (Cartesian Technologies, USA) on the 
surface of aldehyde-coated slides (CEL Associates, Inc.).  On each slide, there were 5 
parallel subarrays for three synthetic target pools, one sample and one negative 
control (Figure 2.1).  After spotting, the slides were incubated in an air-tight box and 
placed in a humidified incubator (37°C, overnight).  The washing of the slides 
proceeded sequentially with 0.2% SDS (2 min), water (2 min), boiling water (2 min), 
sodium borohybride solution (1.0g NaBH4 dissolved in 300 ml phosphate buffered 
saline and 100 ml pure ethanol, 5 min), 0.2% SDS (1 min) and water (1 min).  After 





Figure 2.1 Schematic representation of array fabrication with gene-specific probes 
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Table 2.2 Gene-specific probes, synthetic targets and asymmetric PCR primers 
Asymmetric PCR primers 
SNPs 
Gene-specific probes a  
(Tm, GC content) 
Synthetic targets b 
forward c reverse 
ANGR 
tttttttttttttttcaattctgaaaagtagctaa 













































































HFE63  tttttttttttttttgctgttcgtgttctatgat agttcggggctccacacggcgactctcatG/Catcatag gctccacacggcgactct gaccagctgttcgtgttctatg 
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(48 oC, 42%) aacacgaacagctggtcatccacgtagcccaaa 
LCAT 
tttttttttttttttctcaatgtgctcttccccc 


































a All gene-specific probes were chemically modified with amino at the 5' ends so that they could be immobilized on aldehyde-coated slide.  The 
15-dT tail was introduced to facilitate hybridization by reducing steric hindrance effect.  Tm stands for melting temperature. 
b Allele-specific synthetic oligonucleotides (70-mer) differed from each other by only a single nucleotide (upper case). 
c The forward primers were designed to generate the target strands for hybridization to the probes immobilized on the slides.
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Two 70-mer oligonucleotides differing by only a single base served to simulate allele-
specific targets of each SNP (Table 2.2), and three pools were prepared from them to 
represent all genotypes.  Genomic samples were first amplified by asymmetric PCR 
with another set of primers (Table 2.2) to generate targets of 40-50 base pairs in 
length.  Typically, 20µl cocktail contained Taq DNA polymerase (Qiagen) (0.5U), Q-
solution (4µl), dNTPs (2.5mM), 50-100ng of genomic DNA, forward primer 
(40pmols) and reverse primer (5pmols).  This mixture was denatured at 95°C (5 min), 
followed by 50 cycles of 95°C (15 sec), 50°C (15 sec) and 72°C (15 sec).  The 
amplicons were then pooled and precipitated with 95% ethanol and sodium acetate 
(3M, pH 5.2) (-70°C, 1 hour).  After centrifugation (14,000rpm, 10 min) to remove 
the supernatant, 500ml of 70% ethanol was introduced and another centrifugation was 
performed (14,000rpm, 5 min).  Finally, the pellet was re-suspended with 4µl TE and 
16µl Arrayit™ UniHyb™ Hybridization Solution (TeleChem, USA). 
Four microliter of pooled synthetic targets, concentrated PCR products or ddH2O was 
loaded on one of the subarrays on the slide.  The subarrays were separated from each 
other by cover slips.  The slide was then transferred into a hybridization cassette and 
immersed in a water bath (50oC, 2 hours).  To remove redundant targets, the slide was 
washed with 2 X SSC+0.2% SDS (3 min), 0.2 X SSC+0.2% SDS (3 min), 0.2 X SSC 
(2 min) and dH2O (2 min).  After air-drying, freshly prepared minisequencing mixture 
was loaded on the slide, which typically contained ThermoSequenase DNA 
polymerase (Amersham) (3U), TAMRA-labelled ddNTP (10pmols) and the other 
three regular ddNTPs (10pmols/ddNTP).  The slide was transferred into the cassette 
again to incubate at 50oC (20 min) in the water bath, followed by washing with TENT 
buffer (10 mM Tris-HCl, 1 mM EDTA, 200 mM NaCl, 0.1% Tween-20) (3 min), 50 
mM NaOH solution (3 min) and dH2O (3 min).  After air-drying, the slide was 
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scanned by ScanArray® 5000 scanner (Packard BioScience Ltd, UK).  The laser 
power was kept constant at 95%, whereas the typical setting for the photo-multiplier 
tube (PMT) was 80%. 
Data analysis 
The images obtained were analyzed by QuantArray® 3.0 (Packard BioScience Ltd, 
UK), and the cut-off values were set at 1.96 x standard deviation above the mean 
values of the corresponding SNPs in the negative control panel.  Spot intensities 
above the cut-off values were taken as a positive signal and those equal or below the 
values were taken as no signal.  Correlation of spot intensities between arrays was 




The 20 SNPs of 10 genomic DNA samples were all successfully genotyped by direct 
sequencing (Table 2.3).  These reference 200 genotypes were produced for evaluation 
of the performances of both RFLP and chip-based minisequencing.  Figure 2.2 shows 






Figure 2.2 Demonstration of three genotypes called by direct sequencing 
 
 
AA                                            AC                                            CC 
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Table 2.3 The reference genotypes of 20 SNPs among 10 samples obtained from 
direct sequencing 
SNPs Subjects 
 HCK BJ JG SL G489 G490 G491 G493 G495 G496 
ANGR TT TT TT TT TT TT TT TT GT TT 
ApoAI-75 GA GG GA GG GA GG GA GG GA GG 
ApoAI+83 CC CC CC CC CC CC CC CC CC CC 
ApoBgc CC CC CC CC CC CC CC CC CT CC 
ApoBtz CC CC CC CC CC CC CC cc CC CC 
ApoE112 CT TT TT CT TT CT TT TT TT TT 
ECE CC CC CC CC CC CC CC CC CC CC 
Eln422 GG GA GG GG GG GG GG GG GG GG 
Eln290 TT TT TT TT TT CC CT TT CC CC 
ENOS GG GG GG GG GG GG GG GG GG GG 
F13 CC CC CC CT TT CT CC CC TT CC 
FVIIT CC CC CC CT CC CT CC CT CC CC 
GP3A TT TT TT TT TT TT TT TT TT TT 
HFE63 CC CC CC CG CC CC CC CC CC CC 
LCAT CC CC CC CC CC CC CC CC CC CC 
LPLPvu CC CC TT TT CT CT CC CC CC CC 
PAI-1 AA AA AA AA GA GA GA GG AA AA 
PON2 CC CC GG CC GG GG CC CC CC CC 
TGFb509 CC CC CC CT CT CC CT TT TT TT 
TNFa GG GA GG GG GG GG GG GA GG GG 
 
The genotype in lower case represented a wrong calling by RFLP. 
Those underscored were not correctly genotyped by minisequencing. 
The highlighted genotypes failed to be called by minisequencing. 
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1 2 3 4
RFLP 
RFLP was also performed in this study as a bench mark for SNP genotyping.  
Compared to all reference genotypes, only ApoBtz of G493 was not correctly 
genotyped by RFLP (Table 2.3).  Thus, the concordance rate between sequencing and 
RFLP, which represents the proportion that was in agreement with the reference set 





Figure 2.3 Calling of three genotypes of LPLPvu by RFLP.  





Figure 2.4 illustrates how base calling is accomplished from one of the four arrays, on 
which minisequencing was carried out with TAMRA-ddCTP.  By using the synthetic 
oligonucleotides as targets, an overall concordance rate of 98.3% was obtained.  In 
comparison, only 90.5% genotypes of the genomic samples were specifically 
genotyped.  Four genotypes (2%) were wrongly called, and 15 genotypes (7.5%) 





Figure 2.4 Base calling by minisequencing from TAMRA-ddCTP array.  Synthetic 
targets composed of common homozygotes (1), heterozygotes (2) and rare 








Correlation of spot intensities between arrays  
Pearson’s correlation test was performed to analyze the arrays with synthetic 
oligonucleotides as targets.  Only results from arrays with TAMRA-ddC or TAMRA-
ddU were shown (Table 2.4) because the majority of the 20 SNPs contained either C, 
or T or both alleles.  Overall, the correlation coefficients (mean) from the 
homozygotes were reasonably high (over 90%), except for TAMRA-ddUTP in the 
10th array (highlighted).  This array was consistently correlated poorly with all other 
arrays.  In contrast, correlation coefficients of the heterozygotes were lower (78%-
85%). 
When the positive and negative spots of each array were analyzed separately, it was 
shown that their mean signal intensities and the standard deviations also showed 























Figure 2.5 Array-to-array comparisons showing the mean +/- SD values of the 





Table 2.4 Array-to-array comparison using Pearson’s correlation analysis 
 
A. TAMRA-ddCTP (Homozygote, Allele 1) 
Array 1 2 3 4 5 6 7 8 9 10 
1 1          
2 0.9789 1         
3 0.9447 0.9402 1        
4 0.9704 0.9666 0.9427 1       
5 0.9513 0.9603 0.9590 0.9278 1      
6 0.9685 0.9579 0.8964 0.9369 0.9322 1     
7 0.8983 0.8921 0.9794 0.9022 0.9109 0.8223 1    
8 0.9785 0.9728 0.9188 0.9702 0.9517 0.9647 0.8494 1   
9 0.9538 0.9417 0.9172 0.9719 0.8947 0.9419 0.8695 0.9408 1  
10 0.9462 0.9394 0.9188 0.9449 0.8977 0.9075 0.8822 0.9319 0.9459 1 
Mean: 0.9331 
B. TAMRA-ddCTP (Heterozygote, Allele 1 + 2) 
Array 1 2 3 4 5 6 7 8 9 10 
1 1          
2 0.9024 1         
3 0.9027 0.8234 1        
4 0.8379 0.8922 0.7999 1       
5 0.8359 0.8765 0.8931 0.7503 1      
6 0.9043 0.9037 0.8417 0.7992 0.8966 1     
7 0.7929 0.8272 0.9048 0.7374 0.8910 0.7931 1    
8 0.8916 0.9391 0.7926 0.8467 0.8650 0.9379 0.7434 1   
9 0.8822 0.9072 0.7934 0.8982 0.7884 0.8108 0.7930 0.8554 1  
10 0.8344 0.9035 0.8288 0.9087 0.8347 0.7982 0.8174 0.8397 0.8740 1 
 
Mean: 0.8487 
C. TAMRA-ddCTP (Homozygote, Allele 2) 
Array 1 2 3 4 5 6 7 8 9 10 
1 1          
2 0.9827 1         
3 0.9752 0.9749 1        
4 0.9332 0.9342 0.9357 1       
5 0.9607 0.9484 0.9810 0.9479 1      
6 0.8095 0.8159 0.7951 0.8290 0.7876 1     
7 0.9113 0.8860 0.9224 0.9102 0.9574 0.7793 1    
8 0.9716 0.9573 0.9892 0.9322 0.9885 0.8029 0.9488 1   
9 0.8709 0.8374 0.9136 0.8392 0.9147 0.7367 0.8855 0.9239 1  




D. TAMRA-ddUTP (Homozygote, Allele 1) 
Array 1 2 3 4 5 6 7 8 9 10 
1 1          
2 0.9509 1         
3 0.9618 0.9579 1        
4 0.9703 0.9563 0.9724 1       
5 0.9372 0.9594 0.9578 0.9146 1      
6 0.9941 0.9560 0.9538 0.9619 0.9324 1     
7 0.9778 0.9396 0.9618 0.9705 0.9499 0.9642 1    
8 0.9861 0.9476 0.9522 0.9625 0.9231 0.9817 0.9691 1   
9 0.9650 0.9275 0.9205 0.9185 0.9320 0.9700 0.9559 0.9666 1  
10 0.8934 0.8778 0.8683 0.8614 0.8678 0.9111 0.8945 0.8931 0.9474 1 
 
Mean: 0.9421 
E: TAMRA-ddUTP (Heterozygote, Allele 1 + 2) 
Array 1 2 3 4 5 6 7 8 9 10 
1 1          
2 0.7748 1         
3 0.8656 0.6754 1        
4 0.7083 0.9187 0.7198 1       
5 0.8366 0.7552 0.8974 0.8249 1      
6 0.8536 0.9223 0.7065 0.8084 0.8045 1     
7 0.6903 0.6152 0.6180 0.6050 0.6869 0.7180 1    
8 0.7754 0.9443 0.7349 0.9216 0.8491 0.9221 0.6956 1   
9 0.8246 0.9171 0.7240 0.8649 0.8271 0.9587 0.7004 0.9280 1  
10 0.7027 0.7444 0.6263 0.7197 0.6472 0.7731 0.6549 0.7358 0.7843 1 
Mean: 0.7774 
F. TAMRA-ddUTP (Homozygote, Allele 2) 
Array 1 2 3 4 5 6 7 8 9 10 
1 1          
2 0.8924 1         
3 0.9505 0.8942 1        
4 0.9095 0.9728 0.9314 1       
5 0.9144 0.8003 0.9400 0.8601 1      
6 0.9111 0.9676 0.8784 0.9656 0.7797 1     
7 0.8745 0.9205 0.9246 0.9508 0.9299 0.8744 1    
8 0.9256 0.9711 0.9390 0.9824 0.8263 0.9680 0.9084 1   
9 0.9343 0.9590 0.9117 0.9586 0.8045 0.9738 0.8864 0.9794 1  
10 0.6703 0.7220 0.6879 0.7189 0.5989 0.7675 0.6736 0.7199 0.7117 1 
 Mean: 0.8720 
 52
2.4 Discussions 
In this study, we have successfully adapted minisequencing to solid phase (microarray) 
to perform multiplexed SNP genotyping.  This format permits immediate access of 
the targets to the probes without diffusion, thus remarkably reducing the amount of 
targets required for hybridization.  Significantly, this platform allows accurate 
interrogation of >90% of all SNPs in parallel.  Moreover, it can be easily tailored to 
other biomedical applications as a substitute for many conventional methods.  As a 
demonstration of principle, this study succeeded in genotyping most SNPs. 
Upon hybridization and addition of polymerase, gene-specific probes will be extended 
by a single ddNTP, and the extended probes can be detected if the incorporated 
ddNTP is fluorescently-labelled.  This is a procedure called minisequencing, which 
ensures accurate genotyping with the help of high-fidelity DNA polymerase.  In this 
study, we used ThermoSequenase to perform single-base extension with TAMRA-
labelled ddNTPs, and it demonstrated a concordance rate similar to that of RFLP 
when synthetic targets were genotyped. 
When long PCR products were used to run minisequencing in previous studies carried 
out in our group, the genotype calling rate was very low.  Thus, it was speculated that 
the target size is important for accurate genotyping by minisequencing.  For this 
reason, this study designed another set of primers to run asymmetric PCR to generate 
targets of 40-50mer in length.  This modification greatly improved the performance of 
minisequencing as most of the SNPs were correctly genotyped.  Compared to long 
and bulky targets, small ones are less likely to form hairpins by intra-molecular base 
pairing, thus facilitating efficient hybridization between probes and targets.  
Generation of targets by asymmetric PCR in this study also simplified sample 
preparation, which was usually accomplished by two separate PCR reactions. 
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Because both hybridization and minisequencing are usually performed under one 
temperature, it is thus crucial to design the gene-specific probes with similar Tm 
values to ensure efficient hybridization and even single-base extension.  As the 
optimal temperature of ThermoSequenase used in this study is around 60oC, it is thus 
favourable to have a similar Tm for each probe.  Unfortunately, Tm value and GC 
content of the probes included in this study, calculated by a web tool 
(http://www.basic.northwestern.edu/biotools/oligocalc.html), vary from 36oC to 60oC 
and 29% to 76%, respectively.  As such, some DNA targets might have never 
succeeded to be captured by the probes, which explained to some extent why a higher 
failure rate was obtained by on-chip minisequencing.  The higher failure rate could 
also be attributed to the failure of PCR amplification.  A higher concordance rate was 
obtained from synthetic targets than genomic DNA, which implies that some genomic 
DNA might not be available for hybridization and minisequencing. 
This study has demonstrated the great potential of the solid-phase minisequencing to 
interrogate multiple SNPs simultaneously, but it could be further improved by a few 
ways.  For instance, as the calling of genotypes is based on a one-color strategy, it 
thus requires four arrays to interrogate each SNP.  Other than consideration of cost 
and labour, signal analysis is also complicated as array variations have to be 
normalized before genotypes can be correctly called.  The presence of array variations 
can be seen from Table 2.4, especially those arrays with heterozygotes.  As mentioned 
earlier, better probe design is also potentially able to improve the performance this 
platform.  Moreover, if the amplification of genomic DNA can be guaranteed, it 
would be expected that much higher calling rate could be achieved. 
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CHPATER 3 TAG/ANTI-TAG LIQUID-PHASE PRIMER EXTENSION 




The common disease-common variants hypothesis postulates that SNPs in 
combination may render an individual susceptible to a particular complex disease 
(Cargill et al., 1999).  From a list of currently known SNPs, it is possible to identify a 
subset of them as useful markers for the prediction of disease occurrence, especially 
for complex diseases with high heritability.  Additionally, SNPs are also known to 
contribute to differences in drug responses among individuals (Roses, 2000). 
Although numerous genotyping technologies have been widely in use (Landegren et 
al., 1998; Tsuchihashi et al., 2002), only microarray appears more promising for 
fulfilling the need of a highly multiplexed genotyping platform.  Advances in 
technologies such as oligonucleotide synthesis and high-precision robotic 
microarrayers have enabled the miniaturized solid-phase microarray to interrogate 
thousands of SNPs simultaneously.  In general, there are two categories of 
microarray-based genotyping methods.  One is solely dependent on sequence-specific 
hybridization between complementary DNA strands (Khrapko et al., 1991).  
However, the allele discrimination power of such approach is limited (Ben-Dor et al., 
2000; Lindroos et al., 2002).  The other category consists of enzyme-mediated 
methods, such as DNA polymerase (Pastinen et al., 1997; Lindroos et al., 2003), 
ligase (Consolandi et al., 2003) and endonucleases (Wilkins Stevens et al., 2001).  
Among them, solid-phase primer extension (minisequencing) using DNA polymerase 
is the most robust one.  Gene-specific probes are immobilized on the chip and will 
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anneal just 5' to the polymorphic nucleotide of interest on target DNA.  They are then 
extended by fluorescent ddNTPs and detected.  With this approach, remarkable 
improvements have been made in terms of sensitivity and specificity.  However, this 
approach also bears a few limitations.  For instance, the chips are usually custom-
made by spotting gene-specific probes for the SNPs of interest.  If one or a few SNPs 
need to be included or removed, a fresh chip has to be spotted with the new 
combination of probes.  This inflexibility has been overcome by the introduction of 
the universal tag/anti-tag system (TAT), which allows ‘homing’ of any gene-specific 
sequences to particular anti-tags on chip via their artificial tags (Lovmar et al., 2003).  
In this way, universal chips can be prepared in bulk and used for any combination of 
SNPs later.  Another limitation of solid-phase primer extension is the reduced 
efficiency when many sequences are involved.  From our earlier studies, we 
encountered many SNPs which randomly failed to be genotyped.  This is most likely 
due to limited molecular reaction space for probe-target hybridization (steric 
hindrance effect), especially in the presence of a large amount of long targets.  This 
problem has been addressed by performing primer extension in liquid phase in a 
cyclic manner (Lindroos et al., 2002).  In this way, it also obviates the need to 
generate single-stranded targets.  In solid-phase platforms, it is usually necessary to 
run a second PCR with one primer to produce single-stranded targets or carry out 
other alternative approaches such as asymmetric PCR, or digestion of one strand by 
DNA exonucleases.  In any case, these approaches are either not efficient, tedious or 
not cost-effective. 
Another problem associated with conventional solid-phase primer extension is the 
choice of fluorophore for distinguishing the 4 ddNTPs.  If only a single fluorophore is 
used for all four ddNTPs, four separate extension reactions would have to be 
 56
performed in a parallel manner, one for each ddNTP.  Alternatively, if four 
fluorophores are used to label the ddNTPs, only a single reaction is required.  
However, the problem of crosstalking (overlapping fluorescent signals) becomes an 
issue because it is difficult to select fluorophores that emit at sufficiently different 
wavelengths or have filters in scanners that can discriminate the smaller differences in 
emission wavelengths.  To overcome this problem, we have devised a novel two-color 
detection strategy and integrated it into TAT and liquid-phase prime extension 
systems so that it can interrogate all types of SNPs and some short insertion/deletion 
polymorphisms in a single reaction with only two fluorescent ddNTPs. 
In essence, there are only six types of SNPs: C>T or T>C, A>G or G>A, A>C or C>A, 
G>T or T>G, C>G or G>C, and A>T or T>A (Figure 3.1).  As C>T is the most 
common type, both alleles can be interrogated with one extension primer to be 
extended with either Cy5-ddC or TAMRA-ddU (Figure 3.1a).  As for A>G, extension 
with Cy5-ddC and TAMRA-ddU can also proceed if the extension primer is designed 
from the anti-sense strand (Figure 3.1b).  As for A>C or G>T SNPs, two extension 
primers from both strands are required so that they can be extended by either Cy5-
ddC or TAMRA-ddU (Figure 3.1c, d), and both primers are tagged with the same 
anti-tag sequence.  The challenge to our strategy is seen in genotyping C>G or A>T 
SNPs, although they are less commonly encountered.  For instance, if detection of C 
allele of C>G is achieved with Cy5-ddC, G allele cannot be interrogated simply by 
designing another extension primer from the complementary strand because another 
Cy5-ddC will be introduced.  One solution to this problem is to design allele-specific 
extension primer if the nearest neighbouring nucleotide downstream of G allele is A 
or T so that TAMRA-ddU can be incorporated.  Another solution is to tag the 
extension primers differentially.  Both primers will be extended with Cy5-ddC, but 
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they can be discriminated because the signals are addressed to different sites on the 
chip (Figure 3.1e).  These strategies can also be applied to interrogate A>T SNPs 
(Figure 3.1f).  Thus, all types of point mutations are covered by our two-color strategy.  
These strategies can also interrogate some short insertions/deletions.  LCAT included 
in this study is indeed a single C insertion.  Without this insertion, the subsequent 
base is G.  Thus, the strategies for C>G SNPs were applied.  As a proof of concept, 
we demonstrated this two-color strategy by genotyping a panel of 9 SNPs and 
evaluated it with sequencing and RFLP.  Although this system is currently used for 
genotyping coronary artery disease candidate genes, it can be easily adapted for any 
genes of interest from other diseases or those involved in drug metabolism. 
 
3.2 Materials and methods 
Oligonucleotides 
Five sets of oligonucleotides were used in this study for the following purposes. 
Set 1 was comprised of 10 universal anti-tags initially spotted on the test chip (Table 
3.1).  Typically a universal anti-tag was a 20-mer artificial sequence with an amino-
linker (NH2) at its 3' terminal so that it could be immobilized through a covalent 
bonding with the aldehyde group on the slide.  A poly (T) spacer was also included so 
that it could help reduce steric hindrance effect. 
Set 2 contained 8 pairs of primers for PCR amplification of 9 target sequences (Table 
2.1).  Seven of these SNPs had been previously published (Chamberlain et al., 1989; 
Bujo et al., 1991; Suzuki et al., 1994; Wang et al., 1995; Hibi et al., 1998; Grainger et 
al., 1999; Dachet et al., 2000).  Two SNPs (ELN-422 and ELN-290) were identified 
in our laboratory and they were in close proximity on the same gene.  All these 
primers were used to generate targets for both sequencing and RFLP, and the size of 
 58





Figure 3.1 Schematic representation of two-color strategy to genotype SNPs.  Sense 
strands are represented by thick lines and anti-sense strands by thin lines.  Extension 
primers with the same tag are represented by wavy lines while those requiring 
different tags for the alternate alleles are represented by wavy lines in red. 
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Set 3 consisted of 18 oligonucleotides to simulate allele-specific targets of the 9 SNPs 
to prove the concept of TATLIPEXA.  They also served as reference targets for this 
platform as rare genotypes might not be present in genomic DNA samples (Table 3.2). 
Set 4 were 9 primer pairs designed to amplify the sequences flanking the SNP site to 
produce targets of 40-50bp in length for liquid phase primer extension (Table 2.2).  
This strategy has been proven efficient in improving on-chip minisequencing by 
reducing the complexity of target sequences (Chapter 2). 
Set 5 were 12 extension primers for liquid-phase primer extension.  Some SNPs 
required two extension primers to introduce different fluorescence, such as CETP 
(A>C) and ENOS (G>T) (Table 3.2). 
 
 
Table 3.1 The universal anti-tag sequences used in this study 












Table 3.2 The primers and synthetic targets for liquid-phase primer extension 
SNPs a Extension primers b Synthetic targets c 




ELN-422 (G/A) TAGCGACGTGACTGGATCGAtccgggaacacctccgacac gtgtccctG/Agtgtcggaggtgttcccgga 








LPLpvu (C/T) TCTCATCGGACCACAAGAGGctcaattcaatgtctcttcatcttttag accccacagctG/Actaaaagatgaagagacatt 
TGFb509 (T/C) AGTCGAACTCGTTGAATTTCtctgcctcctgacccttccatcc gacacctgaG/Aggatggaagggtcaggaggc 
a  Except A>T (T>A), all other forms of SNPs are included in this study.  ELN-422 and ELN-290 are novel SNPs identified by our 
group from the elastin gene. 
b The extension primers are chimeric oligonucleotides consisting of a universal tag (upper case) and gene-specific 
sequence (lower case).  Only the extension primers of LCAT were tagged with two different universal sequences. 
c Synthetic targets are short gene-specific sequences flanking the SNPs of interest. 
 61
Array fabrication 
The ready-to-use CSS-100 silylated slides were purchased from CEL association, Inc.  
Prior to printing, the universal anti-tags (Set 1) were re-suspended to a concentration 
of 20μM with ArrayIt™ micro spotting solution (TeleChem, USA), sodium hydroxide 
(0.08M) and TE buffer (pH 8.0) according to the manufacturer’s instruction.  Each 
anti-tag was spotted on the chip in quadruplicates with a 2 x 2 format using the 
PixSys7500 arrayer (Cartesian Technologies, USA), and ten of these cluster of 4 spots 
made up an array.  After an overnight incubation in a humidified chamber at 37°C, the 
slides were sequentially washed twice with 0.2% SDS (2 min); twice with distilled 
H2O (2 min); once with distilled H2O at 95°C (2 min); once with sodium borohybride 
solution (5 min); twice with 0.2% SDS (1 min) and twice with distilled H2O (1 min).  
After air dry, the slides were ready to use or stored at 4°C. 
 
Amplification of target DNA 
Nine polymorphisms (Table 3.2) were selected from those that had been studied by 
our group for their roles in coronary artery disease.  To yield sufficient amplicons for 
both DNA sequencing and RFLP, the PCR was set up in a total volume of 20µl.  
Typically the reaction mixture contained 2% DMSO, 2.5mM dNTPs, 0.2 units of 
DyNAzyme™ II DNA Polymerase (Finnzymes, Finland) and 20pmols of each primer.  
One touchdown PCR program was run to amplify all targets in an automated thermal 
cycler (Biometra) with initial temperature at 95°C (5 min), followed by 15 cycles of 
95°C (30 sec), 63°C (1 min), 72°C (1 min) and another 20 cycles of 95°C (30 sec), 
55°C (1 min), 72°C (1 min).  The reaction was terminated after final extension at 
72°C (10 min). 
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Genotyping by sequencing and RFLP 
The procedures have been described in detail in Chapter 2. 
 
Genotyping by two-color TATLIPEXA 
In order to prove the concept of TATLIPEXA and optimize its reaction conditions, 
three synthetic target pools (Set 3) simulating the 3 respective genotypes of each SNP 
were prepared.  Cyclic liquid-phase primer extension was performed in thermal cycler 
(Biometra) in multiplex format, such that all 12 extension primers were included in a 
single reaction.  Typically the 15µl reaction mixture contained 1pmol of each 
extension primer, 1 unit of ThermoSequenase DNA polymerase (Amersham), 
10pmols of Cy5-ddC and TAMRA-ddU (NEN Life Science).  The cycling was 
initiated at 94°C (3 min), followed by 30 cycles of 94°C (15 sec), 50°C (15 sec) and 
60°C (15 sec).  Subsequently, 5 µl of the reaction mixture were directly placed on the 
chip to allow for hybridization between anti-tags on chip and tags of the extension 
primers.  Hybridization was carried out in a sealed humidified cassette in a water bath 
(55°C, 1h).  The chip was then washed once with 0.2% SDS (5 min) and twice with 
distilled H2O (2 min).  The fluorescence from the chip was acquired with ScanArray® 
5000.  The laser power was kept constant at 95%, whereas the photo-multiplier tube 
(PMT) was typically 80% for Cy5 (633 nm), 85% for TAMRA (575 nm).  For base 
calling, the signal intensities were measured by QuantArray® 3.0 software. 
For genomic DNA samples, amplification by PCR was first performed with primers 
(Set 4) to produce 40-50bp amplicons.  Much less dNTPs (1mM) was used in this 
process because the sequences to be amplified were shorter.  Otherwise, substantial 
amounts of shrimp alkaline phosphatase (SAP) would have to be used to ensure that 
excess dNTPs were completely degraded so that only Cy5-ddC or TAMRA-ddU 
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could be incorporated into the extension primers.  Amplification was also carried out 
under one touchdown program, initial temperature at 95°C (3 min), followed by 20 
cycles of 95°C (15 sec), 55°C (15 sec, -0.25°C/cycle), 72°C (30 sec), another 20 
cycles of 95°C (15 sec), 50°C (15 sec), 72°C (30 sec) and final elongation at 72°C (5 
min).  After PCR amplification, 5µl amplicons of each gene were pooled and treated 
with 1 unit of Exo I to remove redundant primers and 0.5 unit of SAP to degrade 
excess dNTPs (37°C, 30 min, followed by 75°C, 15 min).  The sample was now ready 
for cyclic liquid-phase primer extension, followed by hybridization.  Both reactions 
were carried out under the same conditions as those of the synthetic target pools.  
Finally, the chip was scanned and signal intensity was measured for base calling. 
 
Data analysis 
In this study, the signal intensity ratio of Cy5-ddC against the sum of Cy5-ddC and 
TAMRA-ddU was calculated to set the cut-off values for three genotypes.  The lower 
and upper limits of the cut-off value were the 95% confidence intervals (Mean ± 1.96 




A total of 72 genotype results were obtained by sequencing from the 9 SNPs among 8 
subjects (Table 2.3), which serves as the standard for other genotyping methods. 
 
RFLP 
In comparison with the reference data from sequencing, no discrepancy was found 






As shown in Figure 3.2, all three synthetic target pools were specifically genotyped 
by two-color TATLIPEXA.  The first pool consisted of only C or G allele of all SNPs 
and was genotyped with Cy5-ddC (Figure 3.2A, upper half).  The second pool 
contained all C, G, A and T alleles.  Accordingly, both Cy5-ddC and TAMRA-ddU 
gave signals (Figure 3.2B).  The third pool included only A or T allele, as such, only 
TAMRA-ddU could be incorporated (Figure 3.2C, lower half).  Two clusters in each 
subarray (Figure 3.2, columns 8 and 10) were set aside for LCAT as its extension 
primers were tagged with different sequences.  Even though they were both elongated 













Figure 3.2 Evaluation of the specificity of TATLIPEXA using synthetic targets.  A) 
Synthetic target pool to simulate homozygous C target of all SNPs.  Only Cy5-ddC 
was specifically incorporated into the extension primers (upper half).  B) Synthetic 
target pool to simulate heterozygote of all SNPs.  All extension primers were 
extended by either Cy5-ddC (upper half) or TAMRA-ddU (lower half).  C) Synthetic 
target pool to simulate homozygous T target of all SNPs.  Only TAMRA-ddU (lower 
half) was specifically incorporated into the extension primers. 
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To assess the sensitivity of TATLIPEXA platform, only two synthetic targets 
simulating C and T alleles of ELN-290 were mixed in varying concentrations for 
cyclic liquid-phase primer extension.  The ratio of C allele to T allele (C/T) ranged 
from 0.01 to 100 (100:1, 100:10, 100:100, 10:100, and 1:100).  With as little as 
10fmols of either allele, very strong fluorescence signal was produced (Figure 3.3A).  
When the logarithm of allele ratios (C/T, X-axis) was plotted against that of signal 
intensity ratios (Cy5-ddC/TAMRA-ddU, Y-axis), we found the signal intensities were 
















Figure 3.3 The sensitivity and quantitative feature of TATLIPEXA.  A) Synthetic 
targets corresponding to C and T alleles of ELN-290 were mixed for liquid-phase 
primer extension in the ratios of 100:1, 100:10, 100:100, 10:100 and 1:100.  The 
pseudo-colors of the spots represent different signal intensities, with white for the 
highest, green for the lowest, red or orange for the intensities in between, and blue for 
negative.  10fmols of either allele could be detected.  B) The signal intensities of 
images in A were analyzed and the logarithm of the signal ratios (Y-axis) was plotted 
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The performance of TATLIPEXA in genotyping genomic DNA samples was shown 
in Figure 3.4A.  According to the cut-off values obtained from the signal intensity 
analysis, all 72 genotypes were specifically genotyped in comparison with sequencing 
and RFLP.  The scatter plot analysis also showed three distinct clusters corresponding 
to the three genotypes of all SNPs (Figure 3.4B).  Thus, perfect concordance rates of 
100% were obtained among sequencing, RFLP and two-color TATLIPEXA. 
 















Figure 3.4 Genotyping results of genomic DNA by TATLIPEXA.  A) Genotyping 
results by two-color TATLIPEXA.  The top subarray was positive control, the bottom 
one was negative control, and between them were 8 genomic samples.  In each 
subarray, the fluorescence signal of the upper row was from Cy5, and the lower one 
was from TAMRA.  After subtraction of the background value from the signal, the 
signal intensity ratio of Cy5 against the sum of Cy5 and TAMRA at each site was 
calculated.  In this study, the signal ratio for a CC genotype was >0.89; CT, 0.35–0.66; 
TT, <0.11.  B) Scatter analysis of genotyping results from the representative 9 SNPs 
among 8 subjects.  The X-axis was the signal ratio of Cy5-ddCTP against the sum of 
Cy5-ddC and TAMRA-ddU, while the Y-axis was the logarithm of the total signal 
intensities (Cy5-ddC+TAMRA-ddU).  There were three distinct clusters 
corresponding to CC (48), CT (13) and TT (11), respectively. 
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3.4 Discussion 
The TATLIPEXA platform presents a number of advantages over existing solid-phase 
primer extension platforms.  With the introduction of tag-anti-tag system, the main 
consideration for chip preparation is shifted to the design of the universal anti-tags.  
Essentially, the choices of both the sequence and length of the anti-tags are important 
because higher temperature favours specific hybridization but reduce intra-molecular 
structure formation.  Although the anti-tags used in this study were manually designed, 
they turned out to be very effective as no cross-hybridization was observed.  
Guidelines for design of universal anti-tags are now available (Gerry et al., 1999) and 
are very helpful for array preparation. 
In comparison to solid-phase primer extension, cyclic feature of liquid-phase has 
shown marked improvement in sensitivity as 10fmols of synthetic targets can be 
detected.  As with solid-phase primer extension, the liquid-phase alternative could 
also be performed in multiplex format.  However, prior generation of single-stranded 
targets from PCR products is not necessary in liquid-phase due to its cyclic feature.  
In fact, both strands of amplicons are required for many SNPs using our two-color 
strategy (Figure 3.1c, d, e and f).  Consequently, sample preparation is significantly 
simplified with only conventional PCR amplification and SAP digestion involved.  
However, it is very critical to ensure that excess dNTPs must be completely digested.  
Otherwise, non-specific signal would be generated if dNTPs are incorporated into the 
extension primers prior to fluorescent ddNTPs.  In this study, Exo I was included to 
digest the excess PCR primers.  If not removed, these primers will consume more 
fluorescent ddNTPs since they could also be extended. 
Theoretically it is possible to perform primer extension in a single reaction using 4 
fluorescent ddNTPs (Kurg et al., 2000) as four-laser scanners are commercially 
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available.  In this way, the sample preparation and genotyping procedures can be 
significantly simplified.  However, it is very difficult to choose four dyes for this 
purpose without encountering the problem of signal overlap.  Moreover, it has been 
reported that the incorporation efficiencies of ddNTPs are different (Fortina et al., 
2000).  Given the same amount of target, the signal intensity of Cy5-ddC was 
relatively stronger than that of TAMRA-ddU (Figure 3.3A).  When dye-swap 
experiment using TAMRA-ddC and Cy5-ddU was performed, the stronger signal was 
still from Cy5-ddU.  This implies the fluorophores can contribute to variations in 
signal intensities.  As such, if normalization of the differential signal intensities is not 
carried out, false base calling may result.  On the other hand, if four ddNTPs are 
labeled with only one fluorophore, four separate reactions would have to be 
performed.  This is not time and cost effective, and additional computation has to be 
performed to correct chip-to-chip variations.  Some have attempted to overcome those 
limitations by using two different Cyanine dyes, but their strategy was to group SNPs 
and interrogate them by different reactions (Fan et al., 2000; Fortina et al., 2000).  
The main novelty of this study is the two-color strategy, which allows all SNPs and 
some short INDELs to be interrogated simultaneously in a single reaction.  As 
demonstrated in this study, it is possible to discriminate all types of SNPs and even 
INDELs with the use of only two fluorescently labeled ddNTPs.  We chose Cy5-ddC 
and TAMRA-ddU because firstly, there is virtually no signal overlap between Cy5 
and TAMRA; and secondly C>T SNPs are the most common types.  As there are only 
two fluorescent ddNTPs involved, signal analysis is also simplified.  It should be 
noted that this two-color strategy is completely independent of TAT system and cyclic 
liquid-phase primer extension.  Without TAT system, this strategy can still be applied 
to solid-phase primer extension if the gene-specific probes are designed in the same 
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way as those in liquid-phase.  Nevertheless, generation of single-stranded targets is 
necessary for some SNPs and the sensitivity may be sacrificed. 
The preliminary data also suggested that TATLIPEXA could potentially provide 
quantitative information on allele frequencies using pooled DNA.  This is especially 
useful when new mutations are discovered and their frequencies in the population are 
unknown.  This is useful in large-scale association studies to identify disease-
susceptible SNPs quickly.  However, the signal intensities may not be in proportion to 
the allele frequencies if the saturation value of the confocal scanner is reached.  Thus, 
the sample must be pooled and diluted to an appropriate range. 
In conclusion, by the integration of TAT system and liquid-phase primer extension, 
this platform presents a few advantages over some existing approaches, which include 
the abilities to 1) simplify the target preparation; 2) genotype any SNP in a single 
reaction with only two fluorescent ddNTPs; 3) genotype some short insertion/deletion 
polymorphisms; and 4) estimate allele frequencies of pooled samples. 
 
3.5 Future plans 
Although TATLIPEXA has demonstrated great potential for highly parallel 
genotyping, it can be further improved in a few ways.  For instance, the universal anti-
tags used in this study were manually designed.  If TATLIPEXA will be used for 
large-scale association studies to genotype numerous SNPs, it is desirable to have a 
powerful bioinformatic tool to design these probes.  In this study, genomic DNA was 
amplified separately by multiple PCR, which was not time- and cost-effective.  If 
multiplexed PCR with universal primers or whole genome amplification is 
introduced, target preparation can be remarkably simplified.  Once these problems are 
successfully addressed, a robust platform can be established to run high-throughput 
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genotyping for genome-wide association studies.  Thus far, TATLIPEXA has only 
demonstrated the principle by genotyping a limited number of SNPs among a few 
blood samples.  As such, it is also important to apply TATLIPEXA to large-scale 
association studies to genotype many SNPs of a larger sample size. 
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CHAPTER 4 TDT-ASSISTED PROBE ELONGATION (TAPE): A 




The completion of the whole genome sequencing through Human Genome Project 
(HGP) is undoubtedly one of the most marvellous achievements in human history 
(Lander et al., 2001; Venter et al., 2001).  Consequently, a reference genome 
sequence is now available and the next big inquiry of the post-genome era would be 
the interpretation of this genetic blueprint. 
Only 0.1% of the genome sequences between any two individuals are different.  Other 
than insertions/deletions, tandem repeats, inversions and copy number polymorphisms, 
another main form of genetic variation is single nucleotide polymorphisms (SNPs).  
Although SNPs constitute only a very small fraction of the genome, they are widely 
believed to be the reasons why individuals are different from each other, why some 
are susceptible to certain diseases and resistant to certain drugs while the others are 
not (Tsuchihashi et al., 2002).  Thus, SNPs are greatly valued for their great potential 
applications in genetic studies, drug development and diagnostics.  Nevertheless, 
there is currently a huge gap relating SNPs to complex phenotypes and therein lies the 
big challenge to bridge such a gap.  First, five million SNPs have been validated thus 
far, but only a small fraction of these have potential impacts on diseases or drug 
responses (Rebbeck et al., 2004; Riva et al., 2004).  Second, SNPs associated with 
common diseases are themselves common in both healthy and sick populations.  To 
meet these challenges, dozens of molecular technologies have been successfully 
developed.  However, no strategy has satisfactorily fulfilled the requirement for 
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highly multiplexed high-throughput genotyping until the introduction of the 
microarray (Southern et al., 1999). 
Like Southern blotting, microarray utilizes the principle of hybridization to perform 
genetic analyses.  Typically, a microarray experiment is composed of four events.  
First, the array is fabricated by either in situ synthesis or immobilization of synthetic 
probes.  Second, numerous targets of different sequences are sorted through the 
arrayed probes.  Third, fluorescence is captured by a confocal scanner.  Fourth, 
signals are analyzed by bioinformatic tool (Jain 2000).  Target preparation and allele-
discriminations are not listed in this workflow as they are in principle the same as 
those of traditional approaches.  For instance, genomic DNA is usually amplified by 
PCR, and allele discrimination is achieved by hybridization, primer extension or 
ligation.  The power of microarray is realized in its ability to function as a high 
capacity biological ‘sifter’ that is able to sort thousands of targets efficiently and 
specifically through hybridization.  The application of microarray to monitor gene 
expression is essentially based on the same mechanism as that of genotyping, except 
that mRNA is the target of interest. 
One of the contributing factors to the success of the microarray is the use of 
fluorescence to enable detection of attomoles to femtomoles of targets.  Usually, 
fluorescence is introduced by either direct labeling of the oligonucleotides (Shi 2002; 
Consolandi et al., 2003; Lyamichev et al., 2003; Hardenbol et al., 2005) or through 
enzyme-mediated reactions (Pastinen et al., 1997; Gunderson et al., 2005). 
Terminal deoxyribonucleotidyl transferase (TdT) was first discovered to be involved 
in DNA polymerization in calf thymus almost half a century ago (Bollum 1960).  
However, it was soon found that TdT was very different from other DNA 
polymerases (Deng et al., 1983).  In the absence of a DNA template, it could 
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efficiently polymerize a single-stranded DNA (ssDNA) and is actually less efficient 
with double-stranded DNA (dsDNA), especially blunt ended ones.  With these 
distinctive features, TdT has found wide applications in biomedical researches, such 
as detection of DNA damage and apoptosis.  To exploit this distinctive feature, we 
have developed a versatile strategy termed TdT-assisted probe elongation (TAPE), by 
which array can be fabricated with unmodified oligonucleotides and fluorescently-
labeled nucleotides can be incorporated to targets for detection. 
 
4.2 Materials and Methods 
 
Immobilization of oligonucleotides with NH2 modifier 
Commercially available oligonucleotides with NH2-modifier from 1st BASE 
(Singapore) were re-suspended to 20μM with ArrayIt™ micro-spotting solution 
(TeleChem) prior to spotting on aldehyde-coated slides (CEL) using a PixSys 7500 
arrayer (Cartesian).  The quadruplicate spots were arranged in a 2 x 2 format.  After 
incubation (37°C, overnight), the slides were washed sequentially with 2 x SSC (3 
min), 0.2% SDS (3 min), boiling water (3 min) and water (3 min). 
 
The sensitivity of TAPE 
The oligonucleotide with 3'-NH2 (TCGATCCAGTCACGTCGCTAttttttttttttttt) was 
immobilized as described above.  The 15-dT spacer was introduced to facilitate 
hybridization through the capitalized sequence.  In order to determine the sensitivity 
of TAPE, a 38-mer oligonucleotide tagged with a complementary sequence to the 
probe (TAGCGACGTGACTGGATCGAgggaacacctccgacacc) was serially (1/2) 
diluted from 40fmols/µl to 2.5fmols/µl.  One microliter of these dilutions were 
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separately elongated by TdT (1U) with Cy5-ddC (1pmol) in a 5µl solution at room 
temperature (RT) for 20 minutes, followed by addition of 1µl of 0.5M EDTA (pH 8.0) 
and incubation at 95°C for 10 minutes to inactivate TdT.  These mixtures were then 
loaded on the slide and placed in a humidified cassette to allow for hybridization in a 
water bath (50°C, 1hr).  Finally, the slide was washed sequentially with 2 x SSC (3 
min) and water (3 min, twice), and scanned by ScanArray® 5000 (Packard 
BioScience Ltd, UK) at 90% laser power and 90% PMT. 
 
Incorporation of multiple labelled nucleotides by TAPE 
Another oligonucleotide with 5'-NH2 (tttttttttttttttCCTATACAGTCACTTTT) was 
also immobilized on the slides as described above.  Due to the availability of 3'-OH 
group of this oligonucleotide, elongation by TdT can be carried out on the slide.  The 
objective of this experiment was to find out whether multiple labelled-nucleotides 
could be incorporated by TdT.  For this purpose, three mixtures were prepared, 
containing either 0.5pmols of Cy5-ddU alone, 0.5pmols of Cy5-dU alone, or both 
0.5pmols of Cy5-dU and 2pmols of normal dNTPs.  Each mixture contained 1 unit of 
TdT and was made up to 5µl with deionized water (diH2O).  The mixtures were 
loaded onto three subarrays to permit elongation of the probes on the slide (RT, 20 
min).  Subsequently, the slide was washed and scanned as described earlier. 
In addition, we also carried out elongation of the 38-mer oligonucleotide (20pmols) 
with 40pmols of either biotin-dU, FITC-dU or both.  In this set up, it is only when 
both biotin-dU and FITC-dU are incorporated into the same oligonucleotide that it 
will be captured and detected.  In each reaction, there was 20U of TdT and 400pmols 
of dNTPs.  Following incubation (RT, 2hrs), an aliquot of the mixture was captured 
by streptavidin-coated beads (Dynal Biotech) (RT, 1hr).  After washing, the solution 
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was transferred to 96-well plate to be read by Wallac VICTOR2 V multi-label plate 
counter (PerkinElmer). 
 
The time-based TAPE 
The oligonucleotide immobilized through 5'-NH2 was also used to investigate time-
based TAPE because such reaction could be terminated at various time intervals by 
washing away active TdT and redundant Cy5-ddC from the slide as described earlier.  
The 5µl reaction cocktail contained 1U of TdT, 1pmol of Cy5-ddC, 1µl of TdT buffer 
and 2µl of diH2O.  These were loaded onto the slides and incubated at time intervals 
of 1, 2, 3, 4, 5, 10, 15 and 20 min.  At each time point, the corresponding slide was 
stringently washed to remove TdT and Cy5-ddC before scanning. 
 
3' aminoallylation of unmodified oligonucleotides by TAPE for array fabrication 
A small aliquot (450pmols) of each synthetic oligonucleotide (Table 4.1) was 
elongated in a 15µl solution containing 20U of TdT and 1nmol of aminoallyl-dUTP 
(Fermentas).  The mixture was incubated in a thermal cycler (37°C, 2 hrs), followed 
by heat inactivation (95°C, 10 min).  After the concentration of the oligonucleotide 
was adjusted to 15μM with ArrayIt micro-spotting solution, they were spotted on the 
aldehyde-coated slides as described earlier.  In order to find out the immobilization 
efficiencies of these elongated oligonucleotides, TAPE reaction with Cy5-ddC was 
carried out on the slide. 
 
SNP genotyping by ASMS-TAPE 
One potential application that we have exploited TAPE was SNP genotyping.  This 
was demonstrated by integrating TAPE with allele-specific minisequencing (ASMS).  
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A pair of allele-specific primers has their 3' ends bearing the complementary base of 
the SNP.  The principle behind ASMS-TAPE is that, when the SNP of interest is a 
homozygote, one of the two allele-specific primers will be extended by 
minisequencing with regular ddNTPs, while the other is still available for elongation 
by TAPE with a fluorescent ddNTP.  In the case of heterozygote, both primers will be 
blocked so that no fluorescence can be introduced by the subsequent TAPE reaction.  
In order to prove the principle of ASMS-TAPE, five representative SNPs, C>T, C>A, 
C>G, G>A and G>T except A>T (as we do not have an A > T SNP in our current 
panel) were genotyped using synthetic oligonucleotides (Table 4.1).   Three pools 
were prepared from these oligonucleotides to simulate three genotypes of a SNP.  One 
pool comprised of one allele-specific target of all SNPs to simulate common 
homozygotes, another pool contained the other allele-specific targets to simulate rare 
homozygotes, and the third pool was composed of all targets to simulate 
heterozygotes. 
Allele-specific minisequencing was performed typically in an 8µl cocktail containing 
1 U of ThermoSequenase DNA polymerase, 100fmols of allele-specific primers 
which were complementary to the capitalized sequences of the synthetic 
oligonucleotides listed in Table 4.1, 20fmols of synthetic targets from one of the three 
pools and 20pmols of ddNTPs.  The initial temperature was 95°C (5 min), followed 
by 30 cycles of 95°C (30 sec), 50°C (20 sec) and 54°C (30 sec).  The final extension 
was 60°C (5 min).  Following this, a 2µl mixture with 0.5U of SAP was introduced to 
digest redundant ddNTPs which might compete with Cy5-ddC in subsequent 
elongation by TdT.  After heat-inactivation of SAP (95°C, 10 min), 1µl of this 
solution was mixed with 1 U of TdT and 1pmol of Cy5-ddC to elongate the 
oligonucleotides which were not terminated by ASMS (RT, 20 min).  After 
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inactivation of TdT, the solution was loaded on the array prepared from elongated 
oligonucleotides with aminoallyl-dUTP.   Following hybridization (50°C, 1hr) in a 
water bath and washing (2 x SSC, 3 min; water, 3 min, twice), the array was scanned 
to acquire fluorescence. 
These SNPs were also genotyped by ASMS with four TAMRA-labelled ddNTPs to 





Table 4.1 The synthetic oligonucleotides used for SNP genotyping by ASMS-TAPE 

















* With the exception of the SNP site which is underlined, the two allele-specific 
oligonucleotides of each SNP are complementary to each other. 
These oligonucleotides served as both probes to be immobilized on the slides and 
synthetic targets for allele-specific minisequencing reaction. 
The capitalized sequences of these oligonucleotides are exactly complementary to 
their corresponding allele-specific primers for ASMS. 
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Elongation of RNA fragments by TAPE 
The RNA fragments from frozen liver tissue of mouse were prepared according to the 
standard protocol of Affymetrix.  In brief, total RNA was isolated using Trizol 
reagent (Life Technologies) and then purified with RNeasy Mini Kit (Qiagen).  
Following this, 10µg of purified RNA was reverse transcribed to cDNA with 
Superscript II (Invitrogen).  Subsequently, cDNA was in vitro transcribed to 
biotinylated cRNA using the RNA transcript Labeling Kit (Affymetrix). 
Two reaction mixtures were prepared and both contained 2µl of cRNA fragments and 
1µl of dNTPs (100nM).  100 U of TdT were introduced into only one mixture.  After 
topping up to 20µl with diH2O, the mixtures were incubated in a thermal cycler 






It is shown in Figure 4.1 that TAPE has a good sensitivity of 10fmols.  When the 
amount of the target oligonucleotide was doubled to 20fmols, the signal intensity 
increased correspondingly but plateaued out beyond 20fmols when the saturation 
point of the scanner was reached.  Moreover, TAPE with Cy5-dU or Cy5-dU/dNTPs 
generated much stronger fluorescence (2-3 times higher) than that with Cy5-ddU, 
indicating the occurrence of multiple-incorporation of Cy5-dU (Figure 4.2A).  This 
was further substantiated by performing TAPE with biotin-/FITC-dU.  With the 
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were present, the intensity increased more than 5 folds, implying that both biotin-dU 
and FITC-dU were incorporated into the same oligonucleotide (Figure 4.2B). 
 
             







Figure 4.1 The sensitivity of TAPE with Cy5-ddCTP 
 
 








Figure 4.2 Incorporation of multiple labelled-nucleotides by TAPE.  A) TAPE was 
carried out on the slide with Cy5-ddUTP, or Cy5-dUTP, or a mixture of Cy5-dUTP 
and regular dNTPs; B) TAPE was performed in solution with biotinylated dUTP, or 





















Figure 4.3 shows that intense fluorescence could be obtained within one minute of 
elongation by TAPE with Cy5-ddC.  By incubation of up to 20 minutes, however, the 
fluorescence intensity did not increase correspondingly.  This suggests that elongation 
by TdT is extremely rapid. 
 









Figure 4.3 The time-based elongation by TAPE with Cy5-ddC 
 
 
Array fabrication with unmodified oligonucleotides by TAPE  
Intense fluorescence was observed from all spots after TAPE with Cy5-ddC was 
carried out on the array fabricated from oligonucleotides elongated with aminoallyl-
dUTP.  This implies that elongation was efficient and the amino moiety facilitated the 
immobilization of these oligonucleotides on aldehyde-coated slides (Figure 4.4). 
 
 




Figure 4.4 Evaluation of the attachment efficiency of elongated oligonucleotides.  
This array was fabricated by immobilizing regular oligonucleotides which were 
previously extended by TAPE with aminoallyl-dUTP, and evaluation of the quality of 
this custom-made array was accomplished by another TAPE with Cy5-ddC.  
 
 
SNP genotyping by ASMS-TAPE 
Three pools of five SNPs were all specifically genotyped by ASMS-TAPE using the 
custom-made oligonucleotide arrays mentioned earlier.  The common homozygotes, 
heterozygotes and rare homozygotes were represented by subarray AA, AB and BB, 
respectively.  It could be clearly observed in Figure 4.5A that only one allele-specific 
site of each SNP was fluorescently-labelled in subarray AA, and the other 5 sites were 
fluorescently-labelled in subarray BB, and no fluorescence were observed when two 
alleles were present (subarray AB).  As expected, the pattern of the genotyping result 
by ASMS-TAPE is exactly opposite to that by ASMS with TAMRA-ddNTPs (Figure 
4.5B).  When the signal intensity ratios between alleles were plotted against the 
logarithm values of the sum of the signals, three distinct clusters were observed, 
further confirming the success of both ASMS-TAPE and ASMS in accurately 
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Elongation of RNA fragments by TAPE 
Without TdT, the majority of the cRNA fragments were 100-200 nucleotides in length 
(Lane 2, Figure 4.6).  In the presence of TdT, however, some of these fragments were 
clearly polymerized, as shown by their relatively slower migration (Lane 3, Figure 













This study has demonstrated the multiple applications of the rapid and simple TAPE 
procedure which could be carried out without any specialized laboratory equipment 
except for fluorescence detection.  In the first application, we used TAPE to 
incorporate a modified nucleotide to a regular oligonucleotide.  In our demonstration, 
we have chosen to introduce an aminoallyl-dUTP to a set of oligonucleotides for the 
purpose of immobilizing them onto aldehyde-coated microarray slides.  Although 
modified oligonucleotides can be purchased commercially, the advantage of using 





modified.  For smaller scale requirement, this is cost-saving instead of having to order 
commercially available ones that are sold in a fixed minimum quantity. 
Oligonucleotide arrays are usually manufactured by either in situ synthesis (Fodor et 
al., 1991) or immobilization of pre-synthesized probes by either contact printing or 
inkjet dispensing (Lindroos et al., 2001).  The former approach enables production of 
many arrays with consistent and reproducible features, but their price is still 
prohibitive to many laboratories.  Immobilization method is advantageous in its ease 
of prototyping, rapid implementation and low cost, but it requires the probes to be 
chemically modified using anchors such as an amino group.  This is where our 
method of introducing the amino group using TdT could be aptly applied.  Other than 
gene-specific arrays, universal arrays using oligonucleotide tags can also be 
manufactured.  When chemically synthesized oligonucleotides with 3' amino or biotin 
were used for as the immobilized probe in our TAPE experiments, we found that they 
were unable to block the elongation reaction (Chapter 5), despite the absence of the 
3'-OH group.  This led to a high background noise as probes in spots that were 
supposed to give no signals were also elongated.  The noisy background could be 
eliminated by using TAPE to fabricate the microarray by incorporating aminoallyl-
ddUTP onto 3' terminals of regular oligonucleotide probes for immobilization.  Such 
probes are blocked at their 3' ends and do not contribute to any background noise in 
subsequent genotyping reactions using TAPE.  Besides aldehyde-coated slides, 
streptavidin-coated slides or beads could also be used if the probes are extended with 
biotinylated nucleotides.  However, since TAPE can only elongates probes from 3' 
hydroxyl groups, this procedure cannot be used to prepare arrays with the probes 
immobilized through their 5'-ends. 
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Interestingly, besides being used for fabricating micorarrays, TAPE can also be used 
further downstream in the process to incorporate fluorescent signals when custom-
made arrays are used for carrying out genetic analyses.  As a signal incorporating tool, 
TAPE has shown very good sensitivity as we have demonstrated that at least 10fmols 
of target DNA could be directly detected using Cy5-ddC.  We have shown that TAPE 
reactions using Cy5-dUTP produced signals that were more than 3 times higher than 
Cy5-ddUTP.  Currently, most molecular technologies such as molecular inversion 
probe and GoldenGate assay introduce fluorescence by direct labeling of the 
probes/primers (Oliphant et al., 2002; Hardenbol et al., 2005).  A few methods take 
advantage of enzymes (mainly polymerases) to introduce fluorescent nucleotides for 
detection such as minisequencing (Pastinen et al., 1997).   It was observed that the 
signal obtained by TAPE was always stronger than that by minisequencing under 
similar conditions (Figure 4.5 A, B).  This could be explained by the fact that 
incorporation of nucleotides by TAPE occurs at the 3' of the oligonucleotides with 
little steric hindrances.  In contrast, minisequencing usually takes place in the middle 
of a target strand.  In cases where the extension primers are immobilized, they are 
densely packed on a very small area.  Consequently, some of them might not be 
accessible to polymerase for single-base extension and hence resulting in generating a 
weaker signal. 
One distinctive feature of using TAPE to introduce fluorescence is that it can be 
accomplished by simply mixing all necessary components together and leaving the 
mixture on the bench at room temperature for incubation.  Thus, no special laboratory 
equipment is required for the TAPE reaction per se but a fluorescence reader or an 
array scanner is required for detecting the fluorescent signals.   TAPE is also 
advantageous in its ability to introduce fluorescent nucleotides in an exceedingly 
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rapid manner.  We have shown that strong fluorescent signals could be detected as 
soon as after one minute of incubation.  For some unknown reasons, however, 
elongation of all available oligonucleotides in a reaction could not be achieved by 
TAPE.  This was observed when we carried out two sequential TAPE reactions.  The 
first TAPE was carried out with the addition of excess TdT and regular ddNTPs, 
followed by a second TAPE reaction with 1U of TdT and 1pmol of Cy5-ddC.  It 
turned out that intense signals were still acquired, suggesting that many 
oligonucleotides on the array were not terminated by the first TAPE.  Thus far, it is 
not clear what proportion of the oligonucleotides were elongated.  Additionally, we 
have also observed that TdT permits only a limited number of labelled-nucleotides to 
be incorporated simultaneously.  If these limitations could be addressed, TAPE can be 
a powerful signal amplification tool. 
In the next part of our study, we coupled the signal incorporating function of TAPE to 
ASMS for SNP genotyping using the TAPE custom-made arrays.  All SNPs could be 
interrogated with the use of only one fluorescent ddNTP, such as Cy5-ddC.  In 
contrast, direct genotyping by ASMS requires all four ddNTPs to be fluorescently-
labelled.  We have therefore demonstrated that the oligonucleotide array fabricated 
using TAPE was of sufficiently good quality for genotyping SNPs, and that TAPE is 
well suited as a signal incorporation tool.  However, it is very crucial to optimize 
ASMS to terminate all the allele-specific primers with ddNTPs.  Otherwise, 
background signal generated by TAPE can be very high.  Using ASMS-TAPE, 
heterozygotes genotypes are called based on the absence of signals from the two 
corresponding sites on the array.  As such, this could lead to a spurious call if the 
absence of signal is due to a failure of the reaction.  This problem was addressed by a 
two-color ASMS-TAPE strategy.  In brief, ASMS was first carried out with TAMRA-
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labelled ddNTPs.  In the first stage, all three synthetic oligonucleotide target pools 
were correctly genotyped by ASMS as shown in Figure 4.5B.  In the second stage, 
TAPE was carried out with Cy5-ddC to generate another signal pattern as shown in 
Figure 4.5A.  In this way, a single SNP can be counter-checked in a single assay.  
Scanning for TAMRA gives the results of ASMS while scanning for Cy5 would give 
the results of ASMS-TAPE.  The two-colour strategy therefore provides a very 
confident genotype calling.  It is noteworthy that, other than allele-specific 
minisequencing, TAPE is highly compatible with many other allele-discrimination 
chemistries such as Invader assay.  In one of our trials, for instance, two SNPs were 
successfully genotyped by carrying out the first half of the conventional Invader assay 
(Third Wave) to generate 5'-flaps with free 3'-OH from 3'-phosphorylated signal 
probes.  Following this, TAPE with Cy5-ddCTP was performed in liquid phase to 
elongate those signal probes which were successfully cleaved.  Subsequently, 
hybridization was carried out on oligonucleotide arrays with probes complementary to 
the 5' universal sequences of the signal probes.   In this way, Invader assay can be 
easily adapted to solid support to interrogate numerous SNPs simultaneously for 
large-scale association studies.  Moreover, as a universal signal introduction 
procedure, TAPE is also potential to improve many commercial platforms. 
For gene expression studies using high-density oligonucleotide arrays, RNA 
fragments are often biotinylated during in vitro transcription and subsequently stained 
with phycoerythrin (Lescallett et al., 2004).  In this study, we observed that RNA 
could be polymerized by TdT with dNTPs.  It is thus expected that RNA produced by 
in vitro transcription with normal NTPs can be labelled with fluorescent nucleotides 
through TAPE. 
 88
We conclude from this study that TAPE is a rapid and simple reaction that can be 
exploited in many ways.  These include 1) introduction of modified nucleotides into 
regular probes for immobilization on solid substrate such as aldehyde-coated slides or 
magnetic beads, 2) incorporation of fluorescent nucleotides onto oligonucleotides or 
RNA fragments, thus serving as a signal generating tool, and 3) leveraging on the 
ability of TdT to extend multiple fluorescently labelled dNTPs contiguously, it could 
be used as a signal amplification tool for detecting targets of low abundance. 
 
4.5 Future plans 
In this study, the application of TAPE in genotyping SNPs was demonstrated using 
synthetic oligonucleotides as targets.  Thus, it is worthwhile to investigate the 
performance of TAPE by genotyping blood samples.  As mentioned earlier, it is 
difficult to optimize ASMS to ensure that all primers are terminated by ddNTPs.  
Subsequently, the background signal can be quite high.  Thus, it is favorable to 
integrate TAPE with a better allele-discrimination chemistry.  Moreover, the 




CHAPTER 5 AN UNUSUAL PROPERTY OF TERMINAL 
DEOXYRIBONUCLEOTIDYL TRANSFERASE (TDT): ELONGATION OF 3' 
CHEMICALLY MODIFIED OLIGONUCLEOTIDES 
 
5.1 Introduction 
During PCR amplification and sequencing reactions, hybridization of primers and 
template DNA is required for DNA polymerases to initiate the process of nucleotide 
incorporation at the 3' ends of the primers.  Terminal deoxyribonucleotidyl transferase 
(TdT) was first discovered to be involved in DNA polymerization in calf thymus 
almost half a century ago (Bollum 1960).  Its role in the process of immunoglobulin 
diversity through V(D)J mechanism has been well defined (Gilfillan et al., 1995).  
Initially, it was named calf thymus DNA polymerase.  However, it was soon found 
that TdT was very different from other DNA polymerases (Deng et al., 1983).  
Without the presence of two complementary DNA strands, TdT can still polymerize a 
single-stranded DNA (ssDNA) efficiently.  Indeed, the elongation becomes less 
efficient if double-stranded DNA (dsDNA) is formed, and dsDNA with a protruding 
3' end is preferred to that with recessed or blunt end.  Thus, TdT is unique in that it 
does not require a DNA template and functions at a higher efficiency in the absence 
of a template.  With this distinctive feature, TdT has found wide applications in 
biomedical researches, such as detection of DNA damage and apoptosis (Tornusciolo 
et al., 1995; Piqueras et al., 1996; Rohwer et al., 2000). 
Modification of synthetic oligonucleotide at its 3' end is currently widely used in 
biological studies.  For example, i) 3'-modifiers are frequently introduced into 
oligonucleotides to prevent digestion by exonucleases , ii) Oligonucleotide probes are 
often labeled with non-radioactive fluorophore or enzyme at their 3' ends, iii) 3'-
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biotinylated probes permit indirect introduction of signal through fluorophore-
conjugated streptavidin , and iv) the oligonucleotide probes in our laboratory are 
modified with 3' amino group so that they can be immobilized on aldehyde-coated 
slides for microarray studies.  Regardless of the 3'-modifier present on synthetic 
oligonucleotides, a common effect of these modifications is that the 3'-OH group of 
the last base is replaced.  Consequently, it cannot be used for priming PCR 
amplification or sequencing reaction because the 3'-OH is required for the extension 
of nucleotides by DNA polymerases during DNA synthesis, which proceeds in a 5' to 
3' direction in vivo.   
While using 3'-NH2 modified oligonucleotide probes immobilized on aldehyde-coated 
microarray slides for other studies, we found that these modified probes could not 
prevent elongation by TdT.  In order to determine whether this is a common 
phenomenon for other 3' end modifications, oligonucleotides with other 3'-modifiers 
such as 3'-biotin, 3'-C3 linker and 3'-PO4 were investigated. 
 
5.2 Materials and Methods 
 
Oligonucleotides 
The oligonucleotides with/without 3'-modifiers that have been studied are 
summarized in Table 5.1, and their structures are illustrated in Figure 5.1.  With the 
exception of 3C3Oligo (Operon, USA) and 3BioOligo (Alpha DNA, Canada), all 






Figure 5.1 Illustration of the structures of 3'-modified oligonucleotides that were 
investigated in this study 
 
 
Table 5.1 The oligonucleotides with/out 3'-modifiers included in this study 
Oligonucleotide Sequence and 3'-modifier* 
5N3OHOligo (NH2) tttttttttttttttcctatacagtcactttt (OH) 
3NH2Oligo TCGATCCAGTCACGTCGCTAttttttttttttttt (NH2) 
3OHOligo TAGCGACGTGACTGGATCGAtccgggaacacctccgacac (OH) 
3C3Oligo TAGCGACGTGACTGGATCGAttttt (C3 linker) 
3PO4Oligo TAGCGACGTGACTGGATCGAttttt (PO4) 
3BioOligo TAGCGACGTGACTGGATCGAttcaggtgtcctgttgccccctcc (Biotin) 
5N3POligo (NH2) tttttttttttttttTCGATCCAGTCACGTCGCTA (PO4) 
* The underscored, capitalized sequences are complementary to the capitalized 
sequences without underscores. 
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Immobilization of oligonucleotides with NH2-modifier 
Of the probes tested in this study, only 3NH2Oligo and 5N3POligo can be 
immobilized onto the aldehyde-coated slides as they have a -NH2 modifier at either 
end.  Prior to being spotted, they were re-suspended to a concentration of 20μM with 
ArrayIt™ micro-spotting solution as described earlier.  The spotting was performed 
by a PixSys7500 arrayer with quadruplicate spots for each oligonucleotide in a 2 x 2 
format.  After an overnight 37°C incubation in a humidified oven, the slides were 
washed sequentially with 0.2% SDS (2 min), water (2 min), boiling water (2 min), 
sodium borohydride solution (5 min), 0.2% SDS (2 min) and water (2 min).  The 
3NH2Oligo serves as probes for other 3' modified oligonucleotides.  They have a 15-
dT spacer added to make them more accessible for hybridization. 
The procedure to immobilize aminoallyl-dUTP (aa-dUTP, Fermentas) was exactly the 
same as that of oligonucleotides with NH2-modifier.  Treatment of the slides with 
shrimp alkaline phosphatase (SAP) was carried out with a cocktail containing 0.4U of 
SAP and 0.8µl of 10X buffer (RT, 30min), followed by stringent washing. 
 
Elongation on slide  
Each reaction cocktail contained 1U (0.44 pmols) of TdT (Fermentas), 1μl of TdT 
buffer (5 X) and 1pmol of Cy5-ddCTP (Amersham) and topped up to 5µl with 
deionized H2O.  The relative molar ratio of enzyme to substrate was approximately 
1:2.  This mixture was loaded on the slide for elongation at room temperature for 20 
minutes.  The slide was then washed once with 2% SSC (4min) and twice with 
distilled H2O (3min) before being scanned to obtain the signal of Cy5 (633 nm) by 
ScanArray® 5000 (Packard BioScience Ltd, UK).  Both laser power and photo-
multiplier tube (PMT) were set to 100%.  Finally, the fluorescence intensities were 
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measured by QuantArray® 3.0 (Packard BioScience Ltd, UK).  Following this, a 
reaction mixture containing 10U of Exonuclease I (Exo I, Fermentas) and 0.5μl of 
buffer (10 X) with a final volume of 5μl was loaded on the slide.  The slide was then 
placed in a humidified cassette and incubated in a water bath (37°C, 30min).  After 
washing, the slide was re-scanned to obtain the signal of Cy5. 
 
Elongation in solution 
In this set of experiments, the reaction mixture was prepared as described for 
elongation on slide, with the addition of 50fmols of oligonucleotides which have 
complementary sequences of the probes.  Elongation was similarly carried out at 
room temperature for 20 minutes.  Prior to being loaded on the slide, the reaction 
mixture with TdT was inactivated by both the addition of 1μl EDTA (0.5M, pH 8.0), 
and incubation at 95°C for 15 minutes.  Hybridization was carried out in a sealed 
humidified cassette immersed in a water bath (50°C, 1h).  The slide was subsequently 
washed and scanned to obtain the fluorescence signal as described above. 
Elongation was also carried out on one 3'-biotinylated oligonucleotide (gtcgtgagcggct-
gaggtcgatgctgaggtcgcactcaggtgtcctgttgccccctcc, 58-mer), followed by separation on 
2% agarose gel for visualization of elongated products.  As much more 
oligonucleotides are required to be visualized on a gel, each reaction mixture was 
given 50 pmols of each oligonucleotide and 20U of TdT.  Incubation was also carried 







Elongation of 3'-NH2 modified oligonucleotide 
Prior to elongation by TdT, the oligonucleotide with either 3'-NH2 (3NH2Oligo, 3'-
NH2) or 5'-NH2 (5N3OHOligo, 3'-OH) was immobilized on the slides.  It is clearly 
shown in Figure 5.2A that, in the absence of TdT, Cy5-ddCTP was not incorporated 
onto these oligonucleotides.  When TdT was introduced, intense signals were 
obtained (Figure 5.2A, B), indicating that both oligonucleotides were efficiently 
extended with Cy5-ddCTP.  This demonstrated that oligonucleotides with 3'-NH2 can 
be efficiently elongated by TdT. 
 
 
Figure 5.2 Elongation of regular and 3'-NH2 modified oligonucleotides in the absence 
(TdT-) and presence (TdT+) of TdT (Error bars denote standard deviation) 
 
Elongation of oligonucleotides with 3'-C3 linker or 3'-PO4 modifier 
These oligonucleotides were elongated first by TdT with Cy5-ddCTP in solution, 
followed by hybridization through a common tag to its complementary sequence 
previously immobilized on the slides.  One regular oligonucleotide with free 3'-OH 
(3OHOligo) was included in this experiment as control.  In the absence of TdT, no 
obvious signal could be observed from the control (3'-OH(TdT-)).  In contrast, 
extremely intense fluorescent signal was obtained when TdT was present (3'-
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OH(TdT+)), confirming that TdT is essential for the process of elongation (Figure 
5.3).  Besides the control, the oligonucleotide modified with 3'-C3 linker was also 
efficiently elongated by TdT, and the average signal intensity was only slightly lower 
than that of the control.  However, the signal from the oligonucleotide with 3'-PO4 
was very weak, suggesting that it can resist elongation by TdT (Figure 5.3). 
 
 
Figure 5.3 Elongation of regular, 3'-C3 linker and 3'-PO4 modified oligonucleotides 
 
Elongation of 3'-biotinylated oligonucleotide 
Incorporation of multiple nucleotides into 3'-biotinylated oligonucleotide (58-mer) by 
TdT was observed by gel shift assay (Figure 5.4).  Without the introduction of either 
TdT or dNTPs or both of them, these oligonucleotides could not be elongated (Lanes 
2, 3 and 4).  In the presence of TdT (20U) and different amounts of dNTPs (Lane 5, 
10mM; Lane 6, 100mM), however, the oligonucleotides were clearly polymerized.  
Obviously, the oligonucleotides were not evenly polymerized, but the majority of the 
extension products were longer than 200bp. 
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Figure 5.4 Demonstration of the elongation of 3'-biotinylated oligonucleotide by TdT.   
Lane 1: 50bp DNA ladder; Lane 2: 3'-biotinylated oligonucleotide; Lane 3: 3'-
biotinylated oligonucleotide with TdT; Lane 4: 3'-biotinylated oligonucleotide with 
dNTPs; Lane 5: 3'-biotinylated oligonucleotide with TdT and dNTPs (10mM); Lane 
6: 3'-biotinylated oligonucleotide, TdT and dNTPs (100mM). 
 
Elongation of aminoallyl-dUTP 
The aminoallyl-dUTP was immobilized on aldehyde-coated slide through its NH2 
group before TdT-assisted elongation reaction.  The oligonucleotide with 5'-NH2 
(5N3OHOligo) was simultaneously spotted on the slide as control.  Without treatment 
with SAP, intense signal was only observed from the control oligonucleotide.  When 
the slide was treated with SAP, however, Cy5-ddCTP was efficiently incorporated 
into both aminoallyl-dUTP and the control oligonucleotide (Figure 5.5A, B). 
 
Figure 5.5 Elongation of aminoallyl-dUTP by TdT with (SAP+) and without (SAP-) 
prior treatment with SAP and with a regular oligonucleotide as a control 
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Digestion by Exonuclease I 
Only 3NH2Oligo was used for Exo I digestion experiment after elongation by TdT 
because it can be immobilized on the slide, thus ensuring that any signal reduction 
was not due to washing away of some elongated products from the hybrid.  After 
elongation by TdT with Cy5-ddCTP, intense fluorescence signal was obtained.  
However, with Exo I treatment, the signal became very weak and the signal intensity 
ratio (Exo I+/Exo I-) was reduced to about 20% (Figure 5.6). 
 
Figure 5.6 The effect of Exo I digest on 3'-NH2 oligonucleotides that were previously 




Like other members of polymerase X family, TdT can polymerize DNA by adding 
nucleotides repetitively to its 3' terminus (Ramadan et al., 2004).  However, TdT is 
evidently unique because it can catalyze such process entirely in the absence of DNA 
template.  A common belief is that, an oligonucleotide that is modified at its 3' end 
cannot be polymerized.  This is because DNA synthesis proceeds in 5'→3' direction, 
and the free 3'-OH group of oligonucleotide is required for forming a phosphodiester 
bond with the subsequent nucleotide during chain elongation.  Typically, in vitro 
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synthesis of oligonucleotide advances in an opposite direction (3'→5').  If 3' modifier 
is introduced, however, the terminal 3'-OH will be replaced when synthesis is 
complete.  In the course of conducting another study, we were surprised to observe 
that Cy5-ddC could be incorporated onto 3' modified oligonucleotides by TdT despite 
the terminal 3'-OH sites being unavailable for extension.  These oligonucleotides were 
originally modified with 3'-NH2 to permit their immobilization on aldehyde-coated 
slides.  In this study, the slides were stringently washed to remove unbound 
oligonucleotides after the immobilization procedures.  As such, only 3' NH2-
containing oligonucleotides could remain on the slide after the washing steps.  We are 
therefore confident that the elongation observed was not due to the presence of any 
remaining unmodified oligonucleotides, but that TdT has undoubtedly elongated the 
oligonucleotides despite them bearing a 3'-NH2 modifier. 
One explanation for this phenomenon would be that the 3'-NH2 modifier also carries a 
-OH group which might be recognized by TdT as a substitute for the 3'-OH group on 
the deoxyribose sugar.  As shown in Figure 5.1, other than -OH moieties on the 
phosphate group, another -OH (circled) on the carbon chain is present along with the 
3'-NH2 modifier.  This moiety is initially engaged by succinyl-long chain alkylamino 
(lcaa) group so that the modifier can be attached to controlled pore glass (CPG) 
support.  When oligonucleotide synthesis is complete, succinyl-lcaa will be removed 
and the -OH is then exposed.  To validate this speculation, a few oligonucleotides 
with different 3'-modifiers such as C3 linker and phosphoryl group, were also 
investigated.  As these oligonucleotides could not be immobilized on the slide, TdT-
assisted elongation was performed in solution.  Subsequently, they were hybridized to 
complementary oligonucleotides immobilized on the slide so that fluorescence signal 
could be detected if elongation did occur.  To prevent elongation of immobilized 
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oligonucleotides, the reaction cocktail was treated with EDTA and heated at 95°C for 
15min to inactivate TdT before it was loaded onto the slide.  It was observed that the 
oligonucleotide with 3'-C3 linker could also be efficiently elongated by TdT.  
Through gel shift assay, 3'-biotinylated oligonucleotide was found to be polymerized 
by TdT as well.  These two modified oligonucleotides and 3'-NH2 oligonucleotides 
share an extra -OH group introduced by their respective modifier, despite other 
structural differences in the linkers.  Elongation did not occur without such a -OH 
group, as was the case for 3'-phosphorylated oligonucleotide.  Even if a 5'-NH2 was 
introduced into 3'-phosphorylated oligonucleotide (5N3POligo), Cy5-ddCTP was not 
incorporated.  The main difference between 3'-NH2 and 5'-NH2 modifiers is that an 
extra -OH group is introduced by the former one via its linker while the latter has no 
such group.  This further substantiates our hypothesis that this particular -OH group 
on the linker can be recognized by TdT.  Therefore, we are confident to conclude that 
TdT can elongate 3' modified oligonucleotides if recognizable -OH group is 
introduced. 
We speculate that the unusual elongation by TdT can be partially attributed to its 
template-independent feature.  Even if an appropriate -OH group is introduced and it 
can be recognized by other DNA polymerases, chain elongation will still not occur 
because they are dependent on DNA template for incorporation of complementary 
nucleotides.  As modification of oligonucleotides at their 3' ends is only used for in 
vitro experiments, the physiologically significance of this unusual elongation by TdT 
remains to be investigated.  Nevertheless, our findings have led us to postulate that 
other than the 3'-OH group on the deoxyribose sugar moiety of DNA strand, some 
other molecules with free -OH groups might potentially be able to serve as primer for 
DNA polymerization by TdT.  It is thus important to investigate whether DNA 
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polymerization can occur on 3'-modifiers alone.  If it does, we would expect that 
oligonucleotides could be enzymatically synthesized in the complete absence of DNA 
molecules, except for the provision of dNTPs as building blocks.  Unfortunately, the 
3' modifiers available commercially are all attached to CPG supports and their free 
forms are currently not available for this investigation.  We have yet to find a suitable 
chemical that could be utilized to demonstrate that TdT could incorporate nucleotides 
from a non-DNA primer.  Thus far, we have only managed to investigate whether 
TdT-assisted polymerization can take place with only a single nucleotide.  For this 
purpose, aminoallyl-dUTP was used as the single nucleotide primer.  Surprisingly, 
Cy5-ddCTP was efficiently incorporated into this nucleotide if it was previously 
digested by SAP.  Otherwise, it could not be elongated.  Currently, it is not clear what 
the mechanism behind this phenomenon is, but this finding suggests that TdT can 
catalyze elongation with only a single nucleotide.  This directly challenges another 
belief that TdT requires a primer of at least three bases in length ( Kato et al., 1967; 
Schott et al., 1984; Delarue et al., 2002). 
Exo I can catalyze the removal of nucleotides (3'→5') from ssDNA strand by breaking 
the phosphodiester bond within DNA.  In this study, treatment with Exo I was only 
performed on immobilized oligonucleotides following elongation by TdT.  Other 
oligonucleotides with the various 3'-modifiers that were not immobilized were not 
tested.  This is because they can be washed away from the immobilized probes and 
any decrease in signal intensity cannot be entirely attributed to the action of Exo I.  
Our result showed that the majority of elongated oligonucleotides were digested by 
Exo I, as can be seen by an 80% reduction in signal intensity (Figure 5.6).  The partial 
digestion could be attributed to the high density of the immobilized oligonucleotides, 
in which case some incorporated Cy5-ddCTP could not be easily accessed by Exo I.  
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Nevertheless, the successful digestion by Exo I indicates that canonical 
phosphodiester bonds were formed when oligonucleotides with and without free 3'-
OH groups are elongated by TdT.  This observation does not support the hypothesis 
by another study that an unusual DNA structure is produced by TdT polymerization 
and that such structure is resistant to digestion by nucleases (Ramadan et al., 2004). 
It was reported that human DNA polymerase lambda, another member of polymerase 
X family, could elongate RNA primers (Ramadan et al., 2003).  Through this study, 
we found that TdT could also elongate RNA fragments with dNTPs (data shown in 
previous chapter).  Hence, both DNA and RNA can be elongated by TdT.  All 
nucleotides (dNTPs, NTPs and ddNTPs), regardless of being labelled or not, can 
serve as substrates for such elongation.  It was also observed that elongation by TdT 
was extremely rapid, and very intense signal could be obtained in one minute (data 
shown in previous chapter).  From this study and the work of others, we have strong 
reason to believe that TdT might have more functions to be identified and its 
characteristics are not well defined. 
 
5.5 Future plans 
In this study, all 3' chemically modified oligonucleotides which could be efficiently 
elongated by TdT bear a short DNA sequence.  For this reason, it is not clear whether 
the unusual elongation mediated by TdT also depends on such segment.  Thus, it will 
be of great significance to find out whether TdT can catalyze the addition of 





The initial effort of this thesis was to develop a high-throughput genotyping platform 
by adapting minisequencing onto solid support.  However, it turned out that the 
performance of such a system was not adequate because of poor probe design, 
amplification failure and limitation of the one-colour strategy.  To improve this 
situation, especially to address problems brought from one-colour strategy, a new 
two-colour scheme was devised.  With such scheme, all kinds of SNPs and some 
INDELs could be interrogated simultaneously on a single array.  The significance of 
this strategy can be seen in that it can be easily adapted to most commercial 
genotyping platforms.  For instance, the current version of MIP is a 4-color one so 
that all SNPs can be interrogated on a single array.  However, it requires 4 separate 
reactions for each allele and the upgrade of the scanner to support 4 different dyes is 
also compulsory.  With our 2-color strategy, however, less genomic DNA is required 
because only two reactions are adequate for all alleles.  Moreover, any confocal 
scanner with two different lasers is enough to read the signal.  Compared to the 
current 4-color MIP, the only disadvantage of our 2-color scheme is that 30-40% 
more probes is required.  In this thesis, amplification of genomic DNA was achieved 
by multiple PCR, which is clearly not an efficient way if a large number of SNPs need 
to be analyzed.  Thus, a more effective way to amplify genomic DNA is now under 
investigation and a more efficient genotyping platform is likely to be developed. 
In this thesis, a new universal signal introduction procedure was demonstrated.   This 
method can find wide applications such as genotyping and gene expression profiling.  
It is also noteworthy that this procedure can be utilized to fabricate arrays with regular 
oligonucleotides, thus making array fabrication more flexible and cost-effective. 
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 Another unusual property of TdT, elongation of non-standard DNA molecules with 
an appropriate –OH group, was observed and investigated in this thesis.  This 
phenomenon has never been reported.  However, the biological implication of this 
phenomenon has not been identified thus far. 
In short, this study has mainly demonstrated a new 2-color strategy for SNP analysis, 
and a new universal procedure for signal introduction, array fabrication and qualify 
control.  It is believed that the methods that have been developed in this study offer 
greater flexibility than many other existing genotyping procedures. 
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